Presence of other functional implants

Z21_PRESENCE_OTH_FUNCTIONAL_IMPLANTNTS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z96 Cause of death: ICD-10 — Z96 2 out of 7 registries used, show all original rules.	32914
4. Check minimum number of events None	32914
5. Include endpoints None	32914
6. Filter based on genotype QC (FinnGen only)	32914

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_FAMILY_PERSONAL_HISTORY_CERTA_CONDI_INFLUENCI_HEALTH_STATUS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[8-9]

NAME	Z21_PRESENCE_OTH_FUNCTIONAL_IMPLANTNTS
CONTROL_EXCLUDE	Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_FAMILY_PERSONAL_HISTORY_CERTA_CONDI_INFLUENCI_HEALTH_STATUS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z96
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z96
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Presence of other functional implants based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	32914	18334	14580
Unadjusted period prevalence (%)	6.33	6.25	6.43
Median age at first event (years)	72.55	72.14	73.06

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
18848: Matched controls
150852

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

CKD40

NOMESCO Finland

Endophotocoagulation of retina

18.8

323.0

867

385

S01BC05

ATC

ketorolac; ophthalmic

6.5

323.0

1386

1820

N02BE01

ATC

paracetamol; systemic, rectal

2.1

323.0

15639

105482

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

6.0

323.0

2208

3260

SPAT1153

SPAT

Removal of sutures

2.0

323.0

6569

31349

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

6.8

323.0

990

1228

SPAT1262

SPAT

Handing over of treatment supplies

2.4

323.0

4036

15503

114

Kela drug reimbursment

Glaucoma

4.9

323.0

2939

5528

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

4.5

323.0

2666

5336

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

5.5

323.0

1253

1924

H40.0

ICD-10 Finland

Glaucoma suspect

3.6

323.0

2023

4934

H26.02

ICD-10 Finland

Presenil cataract

14.3

323.0

1715

1045

H26.2

ICD-10 Finland

Complicated cataract

14.5

323.0

697

397

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

150.4

323.0

4234

290

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

87.9

323.0

637

ZXA10

NOMESCO Finland

Bilateral

2.6

323.0

4111

14781

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

25.0

323.0

533

175

H43.1

ICD-10 Finland

Vitreous haemorrhage

7.3

323.0

923

1054

ZXA05

NOMESCO Finland

Left side

2.1

323.0

5355

23690

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

5.3

323.0

10618

29316

H25.1

ICD-10 Finland

Senile nuclear cataract

7.3

323.0

9354

17942

ZXE00

NOMESCO Finland

One hour or less

2.4

323.0

8451

37736

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

323.0

5977

26989

H25.0

ICD-10 Finland

Senile incipient cataract

4.1

323.0

1880

3979

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.8

323.0

2772

8825

XCK00

NOMESCO Finland

Perimetry

3.7

323.0

1740

4050

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.8

323.0

1990

4499

S01EE01

ATC

latanoprost; ophthalmic

5.5

323.0

2052

3278

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

12.5

323.0

899

601

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

17.3

323.0

1331

659

H3603, E103

ICD-10 Finland

25.8

323.0

534

170

B01AB05

ATC

enoxaparin; parenteral

2.4

323.0

6626

28097

S01ED01

ATC

timolol; ophthalmic

6.4

323.0

1340

1793

WX140

NOMESCO Finland

Parabulbar anesthesy

9.0

323.0

2099

2069

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

5.7

323.0

1550

2317

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.8

323.0

3781

12541

S01ED51

ATC

timolol, combinations; ophthalmic

7.1

323.0

3106

4063

CKD60

NOMESCO Finland

Anterior vitrectomy

39.1

323.0

472

WX100

NOMESCO Finland

Conjunctival surface anesthesia

4.9

323.0

3566

6868

WX320

NOMESCO Finland

Spinalanesthesy

2.3

323.0

4956

20585

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

7.1

323.0

1629

1996

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

13.7

323.0

794

484

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

323.0

8450

39843

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

10.9

323.0

1045

811

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

323.0

7243

36274

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

3.6

323.0

3033

7545

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

54.5

323.0

652

H25.8

ICD-10 Finland

Other senile cataract

6.5

323.0

3981

5998

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

9.0

323.0

841

774

S01EC04

ATC

brinzolamide; ophthalmic

6.7

323.0

1252

1582

XCK10

NOMESCO Finland

Photography of fundus of eye

3.5

323.0

2766

7079

Z96.1

ICD-10 Finland

Presence of intraocular lens

422.7

323.0

14397

1147

WX002

NOMESCO Finland

Sedation and analgesia

2.6

323.0

4651

16779

H33.0

ICD-10 Finland

Retinal detachment with retinal break

7.9

323.0

1248

1338

S01EC01

ATC

acetazolamide; systemic

8.6

323.0

881

851

H26.4

ICD-10 Finland

After-cataract

11.8

323.0

4309

3691

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

9.8

323.0

891

759

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.7

323.0

1842

4278

XCW99

NOMESCO Finland

Other investigative procedure of eye

4.3

323.0

3368

7201

XCH00

NOMESCO Finland

Eye pressure measurement

5.0

323.0

1170

1959

ZXA00

NOMESCO Finland

Right side

2.1

323.0

5742

25687

S18

ICPC

Laceration/cut

1.9

323.0

8033

42586

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

15.1

323.0

13326

20740

CJB10

NOMESCO Finland

Laser discission of secondary cataract

13.1

323.0

3959

3003

CKC12

NOMESCO Finland

Photocoagulation of retina

4.6

323.0

1387

2537

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

4.5

323.0

1855

3568

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

6.1

323.0

1269

1750

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

4.4

323.0

1319

2509

C03CA01

ATC

furosemide; systemic

2.2

323.0

5727

25264

Z97.4

ICD-10 Finland

Presence of external hearing-aid

393.0

323.0

666

A10AE04

ATC

insulin glargine; parenteral

3.0

323.0

2180

6276

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

6.2

323.0

1061

1429

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.1

323.0

4488

19203

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

17.1

321.7

554

267

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

316.9

8129

44017

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

5.1

316.4

1108

1823

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

307.1

4101

17244

H20.1

ICD-10 Finland

Chronic iridocyclitis

15.3

306.0

549

295

127

Kela drug reimbursment

Transplant complication

126.2

305.6

356

A10AA01

ATC

7.2

305.3

813

938

A10AA02

ATC

5.5

302.2

996

1526

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

5.6

299.2

968

1450

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

295.9

2983

10946

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

3.2

294.2

1802

4885

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

7.0

294.1

795

937

SPAT1263

SPAT

Sampling

1.8

289.5

7474

40159

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

5.9

287.7

885

1244

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

286.2

7104

37630

T89

ICPC

Diabetes insulin dependent

5.1

285.7

993

1616

Z96.4

ICD-10 Finland

Presence of endocrine implants

2373.5

284.8

300

A10AE05

ATC

insulin detemir; parenteral

3.8

281.5

1350

3017

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

280.0

11046

67548

WX110

NOMESCO Finland

Local anesthesy

1.8

279.1

11737

73170

A02BC02

ATC

pantoprazole; systemic

1.8

278.6

11799

73691

Z94.0

ICD-10 Finland

Kidney transplant status

+∞

269.0

281

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

22.8

267.2

418

150

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

262.5

4030

17799

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

256.5

7759

43306

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

10.9

250.2

521

392

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

249.6

4782

22911

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

248.2

5345

26670

ZXD05

NOMESCO Finland

Urgent procedure

1.8

244.6

5290

26409

S01EE05

ATC

tafluprost; ophthalmic

4.8

243.1

904

1580

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

240.2

7023

38556

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

22.4

240.0

377

137

C07AB07

ATC

bisoprolol; oral

1.7

236.4

8529

49721

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

5.0

235.2

841

1408

SPAT1301

SPAT

No procedures

1.8

232.0

5587

28790

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

4.4

231.2

922

1730

H04AA01

ATC

glucagon; nasal, parenteral

7.3

230.3

608

690

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

227.3

2385

8829

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

+∞

222.9

233

L90

ICPC

Osteoarthrosis of knee

2.9

220.1

1494

4307

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

218.7

3089

13063

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.4

218.7

1212

3027

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

217.1

5192

26573

SPAT1325

SPAT

Vaccination

1.7

216.9

6080

32683

H3601, E103

ICD-10 Finland

14.8

210.8

382

210

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

22.1

209.9

331

122

H3603, E113

ICD-10 Finland

13.2

208.8

397

245

H3601, E113

ICD-10 Finland

7.7

208.8

529

563

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

7.5

208.7

539

591

S01EX03

ATC

6.0

208.2

630

863

C01DA14

ATC

isosorbide mononitrate; oral

2.1

208.1

2741

11231

Z94.7

ICD-10 Finland

Corneal transplant status

+∞

206.6

216

H36.01

ICD-10 Finland

Diabetic maculopathy

10.2

205.9

443

355

H26.3

ICD-10 Finland

Drug-induced cataract

21.1

205.7

329

127

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.8

204.1

1526

4671

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

201.8

2524

10098

S01EE03

ATC

bimatoprost; ophthalmic

5.7

200.4

635

922

J01DB01

ATC

cefalexin; oral

1.7

200.3

14170

96998

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

19.1

198.2

327

139

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.0

197.6

2917

12505

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

6.9

195.3

534

637

H02AB06

ATC

prednisolone; systemic

1.6

193.7

8293

49639

TCG10

NOMESCO Finland

Removal of sutures from cornea

37.7

192.4

265

S01EA03

ATC

apraclonidine; ophthalmic

10.5

190.7

404

314

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.5

190.2

742

1358

CKC10

NOMESCO Finland

Local photocoagulation of retina

6.1

189.6

569

771

SPAT1312

SPAT

General health counselling

1.7

188.6

5391

28863

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

3.7

187.8

902

2002

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

187.4

2728

11604

SPAT1310

SPAT

Counselling related to known health issue

1.7

187.3

5517

29782

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

14.1

187.1

346

200

N02AX02

ATC

tramadol; systemic, rectal

1.6

186.3

7621

44929

H3600, E103

ICD-10 Finland

11.8

186.0

372

257

CKD20

NOMESCO Finland

Removal of vitreous body substitute

22.3

184.0

289

105

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.4

183.5

738

1392

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

182.8

3551

16806

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.5

181.6

710

1302

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

181.3

5080

26981

C08CA01

ATC

amlodipine; oral

1.6

180.6

6389

36182

H36.00

ICD-10 Finland

Diabetic background retinopathy

7.7

179.8

455

483

L04AA06

ATC

mycophenolic acid; systemic

11.1

178.1

367

270

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

+∞

177.8

186

S01EC03

ATC

dorzolamide; ophthalmic

7.4

177.6

462

512

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

3.4

177.5

959

2340

A02BC05

ATC

esomeprazole; systemic

1.6

177.3

7088

41376

CKC15

NOMESCO Finland

Panretinal photocoagulation

11.9

175.6

350

240

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.2

174.9

517

686

Z96.5

ICD-10 Finland

Presence of tooth-root and mandibular implants

27.0

174.7

260

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

173.5

3885

19226

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.7

172.9

844

1897

S01BC03

ATC

diclofenac; ophthalmic

4.6

171.6

656

1175

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

35.2

171.1

239

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.7

169.9

1280

3921

B01AA03

ATC

warfarin; systemic

1.8

169.4

3467

16643

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

168.4

3494

16847

H27.1

ICD-10 Finland

Dislocation of lens

49.4

168.2

220

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

6.8

166.2

459

555

R06.0

ICD-10 Finland

Dyspnoea

1.7

166.1

4168

21324

CKD15

NOMESCO Finland

Injection of vitreous substitute

23.1

164.7

256

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

163.8

3977

20131

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

163.7

2491

10734

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

163.3

2046

8137

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

17.4

162.7

277

129

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

162.0

3144

14798

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

161.9

2143

8723

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

161.3

7684

46472

H3600, E113

ICD-10 Finland

7.3

160.6

420

469

C10AA01

ATC

simvastatin; oral

1.5

160.2

7942

48457

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

4.5

160.0

621

1129

AN1

Coronary angiography

2.2

159.2

1907

7427

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

5.0

157.9

551

894

L89

ICPC

Osteoarthrosis of hip

3.5

157.5

817

1928

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

157.1

5040

27564

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

156.8

4979

27157

L13

ICPC

Hip symptom/complaint

1.9

156.0

2855

13147

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

155.4

1103

3251

S01AX11

ATC

[U] ofloxacin; ophthalmic

3.5

155.0

810

1923

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

154.4

2305

9840

SPAT1211

SPAT

Application of soft bandage

2.3

153.9

1669

6205

J01MA12

ATC

levofloxacin; systemic

1.8

153.3

3428

16865

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

28.3

152.5

224

S01EC54

ATC

brinzolamide, combinations; ophthalmic

7.9

152.4

380

394

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

151.8

5598

31680

XCD10

NOMESCO Finland

Electrophysiological examination of eye

4.3

150.9

612

1162

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

6.5

150.7

429

541

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.4

150.2

492

742

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

147.8

3480

17373

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.2

147.3

1762

6846

SPAT1053

SPAT

Memory test

1.9

147.0

2516

11291

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

146.0

4197

22197

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

39.2

145.9

199

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.9

143.5

950

2674

T90

ICPC

Diabetes non-insulin dependent

1.7

143.0

4161

22058

AA1AD

NOMESCO Finland

CT of head and brain

1.7

142.9

3960

20708

WX142

NOMESCO Finland

Sub-tenon anesthesy

18.0

142.8

240

108

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

142.4

1752

6889

A02BC01

ATC

omeprazole; systemic

1.6

141.6

4834

26726

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

16.0

140.8

247

125

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

8.2

139.6

339

337

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

139.3

1611

6157

H35.37

ICD-10 Finland

Macular holes

6.1

139.2

416

560

C09AA05

ATC

ramipril; oral

1.6

138.7

4255

22851

SPAT1260

SPAT

Consultation of another employee

1.8

136.8

3006

14645

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

6.2

136.2

399

523

M79.6

ICD-10 Finland

Pain in limb

1.5

136.1

5709

33130

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

135.7

4205

22624

J01FF01

ATC

clindamycin; systemic

1.6

135.4

4576

25182

H40.9

ICD-10 Finland

Glaucoma, unspecified

5.5

134.4

431

634

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

4.4

134.2

535

998

B01AC04

ATC

clopidogrel; oral

1.8

133.6

2564

11942

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

73.6

133.2

164

205

Kela drug reimbursment

Chronic hypertension

1.6

132.6

5190

29585

UDC00

NOMESCO Finland

Ear microscopy

2.4

132.6

1287

4518

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

20.1

132.2

214

L28

ICPC

Limited function/disability (L)

1.8

132.0

2552

11910

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

132.0

1459

5456

N18.8

ICD-10 Finland

Other chronic renal failure

4.0

130.9

579

1192

G04CA02

ATC

tamsulosin; oral

1.6

129.4

4515

24991

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

129.1

5865

34562

137

Kela drug reimbursment

Uraemia requiring dialysis

14.6

128.7

234

130

E10

ICD-10 Finland

Type 1 diabetes mellitus

5.4

127.8

417

626

S01EE04

ATC

travoprost; ophthalmic

4.4

127.5

503

929

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

127.2

2322

10614

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

9.6

126.8

280

236

N03AX16

ATC

pregabalin; oral

1.6

125.8

3881

20786

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.3

125.3

701

1750

A10AE06

ATC

insulin degludec; parenteral

3.8

125.0

589

1282

C10AA05

ATC

atorvastatin; oral

1.5

124.4

6684

40766

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.9

124.2

446

747

WX199

NOMESCO Finland

Other local analgesia

3.9

123.9

563

1187

Z49.1

ICD-10 Finland

Extracorporeal dialysis

7.4

123.0

319

352

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

9.9

121.2

264

217

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

119.5

2205

10101

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

119.4

2375

11157

R42

ICD-10 Finland

Dizziness and giddiness

1.6

118.7

3422

17959

CS494

NOMESCO Finland

Other visual field testing

4.0

118.3

517

1052

C07AB02

ATC

metoprolol; systemic

1.6

117.8

3588

19104

UJF32

NOMESCO Finland

Coloscopy

1.6

117.6

4338

24239

B05DA

ATC

Isotonic solutions

18.1

117.6

197

M01AX05

ATC

glucosamine; oral

1.6

116.9

3648

19541

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

13.4

116.9

220

133

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

116.5

1603

6579

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

116.1

1650

6860

H40.11

ICD-10 Finland

Low pressure glaucoma

4.3

116.1

467

879

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

54.5

116.1

149

L15

ICPC

Knee symptom/complaint

1.6

115.4

3458

18317

A11CC03

ATC

alfacalcidol; systemic

4.5

114.4

447

817

I25.2

ICD-10 Finland

Old myocardial infarction

2.4

114.0

1120

3944

Angiography of the heart and coronary arteries

2.5

112.9

1009

3383

UKC02

NOMESCO Finland

Cystoscopy

1.7

112.7

2979

15235

S97

ICPC

Chronic ulcer skin

2.5

112.3

961

3148

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

32.0

111.8

159

CG2T4

NOMESCO Finland

Topography assessment of cornea

9.1

111.6

253

224

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

7.5

111.5

284

305

Z49.2

ICD-10 Finland

Other dialysis

16.4

111.3

193

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

110.3

848

2613

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.8

110.3

256

236

J01MA02

ATC

ciprofloxacin; systemic

1.4

108.7

6562

40662

SPAT1254

SPAT

Administration of medicine

1.8

107.6

2181

10284

H35.36

ICD-10 Finland

Macular cyst

10.1

107.6

231

185

TK800

NOMESCO Finland

Hemodialysis

4.6

107.2

407

723

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

106.6

1175

4371

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

106.6

2223

10575

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

106.4

4130

23264

N02AA05

ATC

oxycodone; systemic

1.7

104.6

2401

11761

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

892.6

104.0

111

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.8

104.0

729

2123

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

11.4

103.9

210

149

A12AA04

ATC

calcium carbonate; oral

5.6

103.3

325

467

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

8.9

102.9

237

216

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

102.7

659

1810

E0000UV

ATC

1.4

102.6

6099

37560

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

102.3

4126

23412

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

12.6

102.3

197

126

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

37.6

102.0

140

XKD00

NOMESCO Finland

Uroflowmetry

1.6

101.7

3049

16086

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

100.8

4272

24499

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

100.4

4320

24854

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

100.2

1599

6928

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

99.2

2752

14212

R53

ICD-10 Finland

Malaise and fatigue

1.6

99.2

2920

15324

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

99.1

1683

7460

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

98.1

1660

7345

N03AX12

ATC

gabapentin; oral

1.7

97.9

2435

12193

B05DB

ATC

Hypertonic solutions

16.7

97.7

168

C09AA02

ATC

enalapril; systemic

1.6

97.5

3510

19363

CHD00

NOMESCO Finland

Laser trabeculoplasty

5.6

97.4

308

446

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

8.9

97.2

223

202

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

55.6

96.9

124

A46

ICD-10 Finland

Erysipelas

1.7

96.3

2285

11282

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

96.2

1797

8227

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.7

96.0

464

1031

-44

ICPC

Preventive immunization/medic

2.0

96.0

1376

5722

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.2

95.9

1046

3869

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

95.8

1922

9010

Z96.2

ICD-10 Finland

Presence of otological and audiological implants

+∞

95.5

100

L04AA01

ATC

[U] ciclosporin; systemic

4.9

95.4

336

551

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

4.3

95.0

385

730

WX144

NOMESCO Finland

Subconjunctival anesthesy

6.8

94.7

257

304

H52.1

ICD-10 Finland

Myopia

3.5

94.3

489

1151

SPAT1229

SPAT

Assessment of need for aid

2.0

94.1

1269

5146

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.2

93.9

246

276

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

10.5

93.9

197

151

M04AA01

ATC

allopurinol; systemic

1.7

93.8

2232

11021

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

11.5

93.6

188

132

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

10.2

93.5

199

157

H34.8

ICD-10 Finland

Other retinal vascular occlusions

3.6

93.4

458

1030

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.9

93.0

608

1691

XCD20

NOMESCO Finland

Photoangiography of eye

4.2

92.3

384

747

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

3.1

92.3

552

1444

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

91.8

6276

39455

V03AE01

ATC

polystyrene sulfonate; oral

5.8

90.7

277

384

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.8

90.5

328

555

L04AD01

ATC

ciclosporin; systemic

4.7

90.4

337

588

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.0

90.2

240

276

I50.0

ICD-10 Finland

Congestive heart failure

2.2

90.0

1059

4051

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

89.9

855

2955

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

89.9

1216

4935

CHC05

NOMESCO Finland

Iridotomy

4.2

89.7

368

706

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

89.7

1963

9442

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

13.8

89.7

166

H25.9

ICD-10 Finland

Senile cataract, unspecified

4.4

89.1

350

644

C08CA13

ATC

lercanidipine; oral

1.7

88.4

2143

10626

G47.3

ICD-10 Finland

Sleep apnoea

1.5

88.3

3508

19734

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

88.2

1896

9068

WX723

NOMESCO Finland

CPAP therapy

2.7

88.1

677

2082

B03XA02

ATC

darbepoetin alfa; parenteral

4.2

87.4

358

686

M48.0

ICD-10 Finland

Spinal stenosis

1.7

86.7

2001

9776

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

13.7

86.6

161

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

86.5

1105

4378

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

86.5

1886

9054

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

86.0

5123

31299

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

85.8

2230

11273

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

85.7

1689

7856

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.8

85.6

398

856

CA1ME

NOMESCO Finland

Ultrasound oculometry

7.8

85.5

212

219

SPAT1216

SPAT

Assessment of functional ability

1.6

84.9

2298

11745

207

Kela drug reimbursment

Chronic arrhythmias

1.7

84.5

2190

11055

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

84.4

2761

14818

CHD99

NOMESCO Finland

Other filtering operation

19.2

84.3

138

S01EB01

ATC

pilocarpine; ophthalmic

6.9

83.8

226

265

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

83.8

1735

8195

H16.0

ICD-10 Finland

Corneal ulcer

2.4

83.8

768

2603

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.3

83.7

838

2971

I44.2

ICD-10 Finland

Atrioventricular block, complete

4.2

83.4

347

675

R4180

NOMESCO Finland

Podiatric therapy

5.4

83.3

270

403

H33.3

ICD-10 Finland

Retinal breaks without detachment

2.5

83.3

700

2264

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.8

83.3

1600

7374

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

10.8

83.0

172

129

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

82.9

1056

4177

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

82.3

3054

16879

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

82.1

1942

9545

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

81.6

1435

6419

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.4

81.4

742

2509

S01FA04

ATC

cyclopentolate; ophthalmic

4.7

81.3

298

511

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

81.1

1670

7868

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.2

80.8

924

3485

A10BA02

ATC

metformin; oral

1.4

80.8

4639

28078

B01AF01

ATC

rivaroxaban; oral

1.7

80.7

1951

9647

H02AB04

ATC

methylprednisolone; systemic

1.6

80.7

2342

12178

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.2

80.5

884

3275

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

43.0

80.2

107

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

15.9

80.1

140

I49.5

ICD-10 Finland

Sick sinus syndrome

3.3

79.8

436

1069

S01ED02

ATC

betaxolol; ophthalmic

5.4

79.8

260

391

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

79.7

1214

5154

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.2

79.5

207

231

NHQ40

NOMESCO Finland

Amputation of toe

3.8

78.9

362

770

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

78.4

1194

5068

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.7

78.4

1710

8198

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

+∞

78.3

A10BB12

ATC

glimepiride; oral

1.9

78.0

1233

5307

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

30.8

77.6

111

SPAT1377

SPAT

Polysomnography

2.6

77.5

632

2010

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

3.4

77.2

408

975

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

7.8

77.2

191

197

DAX08

NOMESCO Finland

Fitting of hearing aid

2.9

76.9

516

1460

V03AE02

ATC

sevelamer; oral

14.5

76.9

139

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.4

76.7

409

984

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

76.5

1156

4891

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

76.4

9476

65018

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.8

75.7

519

1489

A28

ICPC

Limited function/disability NOS

1.6

75.4

2058

10517

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

4.9

75.1

268

447

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

74.6

2658

14516

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.7

74.5

574

1766

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

8.3

74.5

177

171

SPAT1043

SPAT

Audiometry

1.7

74.4

1600

7631

NFB99

NOMESCO Finland

Other primary prosthetic replacement of hip joint

9.0

74.0

168

150

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.1

74.0

920

3597

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.6

73.9

2005

10221

B01AX06

ATC

[U] rivaroxaban; oral

3.0

73.8

459

1233

J01CA04

ATC

amoxicillin; systemic

1.3

73.6

12967

93571

CJF10

NOMESCO Finland

Secondary implantation of artificial lens in posterior chamber

53.9

73.3

H27.0

ICD-10 Finland

Aphakia

16.2

73.3

127

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

72.7

1855

9299

I20.09

ICD-10 Finland

Unstable angina

2.2

72.6

849

3232

H13

ICPC

Plugged feeling ear

1.5

72.3

2739

15161

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

4.6

72.0

269

471

CKC60

NOMESCO Finland

Local buckling of sclera using implant

7.3

71.8

186

206

H81

ICPC

Excessive ear wax

1.5

71.7

2504

13599

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

71.2

1956

10000

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

71.1

1949

9960

J01DA01

ATC

[U] cefalexin; systemic

1.3

71.1

10222

71338

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

6.9

70.8

191

225

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

70.7

1020

4236

R55

ICD-10 Finland

Syncope and collapse

1.7

70.6

1565

7528

R60.0

ICD-10 Finland

Localized oedema

1.7

70.3

1647

8052

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

70.3

915

3648

A10AA03

ATC

5.7

69.9

216

305

WZA90

NOMESCO Finland

Other doctors statement

1.5

69.4

3333

19389

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.3

69.3

375

913

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.5

69.2

345

788

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

69.1

1082

4636

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

69.0

7830

52694

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

69.0

1003

4178

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

6.6

68.6

191

235

H26.1

ICD-10 Finland

Traumatic cataract

10.6

68.6

143

109

R50.9

ICD-10 Finland

Fever, unspecified

1.6

68.3

2028

10574

M09AX01

ATC

hyaluronic acid; parenteral

2.1

68.3

870

3438

Z01.2

ICD-10 Finland

Dental examination

1.3

68.2

5899

38076

WX780

NOMESCO Finland

Remote monitoring CPAP

2.3

67.9

678

2399

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.8

67.6

467

1346

H26.9

ICD-10 Finland

Cataract, unspecified

3.8

67.4

313

674

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

67.3

5054

31865

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

11.8

67.2

133

K02.1

ICD-10 Finland

Caries of dentine

1.3

67.2

8146

55271

SPAT1097

SPAT

Recording of ECG

1.5

67.1

2302

12433

SPAT1281

SPAT

Other administrative function

1.8

67.0

1201

5397

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.1

66.4

862

3431

Z45.1

ICD-10 Finland

Adjustment and management of infusion pump

123.7

66.4

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

22.4

66.3

103

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

66.2

3160

18337

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

65.9

2088

11060

CKC70

NOMESCO Finland

Circular buckling of sclera

10.6

65.9

137

104

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.7

65.8

1498

7257

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

65.6

3738

22438

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

6.2

65.6

191

250

H91.1

ICD-10 Finland

Presbycusis

2.1

65.6

792

3058

CJE15

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

6.2

65.2

189

246

L17

ICPC

Foot/toe symptom/complaint

1.4

65.1

3768

22682

AS4

Physiological pacemaker insertion DDD (R)

6.7

65.1

179

217

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

9.5

65.0

143

121

C03DA01

ATC

spironolactone; oral

1.7

64.9

1507

7343

M54.5

ICD-10 Finland

Low back pain

1.4

64.7

4589

28619

B01AF02

ATC

apixaban; oral

1.7

64.4

1353

6398

N18.0

ICD-10 Finland

End-stage renal disease

4.9

64.4

226

371

C09CA01

ATC

losartan; oral

1.4

64.3

3783

22832

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

3.5

64.3

331

776

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

10.2

64.3

136

107

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

63.7

785

3058

N05CF01

ATC

zopiclone; oral

1.4

63.1

5115

32579

196

Kela drug reimbursment

Paricalcitol and cinacalcet

14.7

62.9

113

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

12.9

62.9

119

D07AC01

ATC

betamethasone; topical

1.3

62.8

5333

34212

H40

ICD-10 Finland

Glaucoma

4.6

62.8

233

406

C03AA03

ATC

hydrochlorothiazide; oral

1.7

62.7

1574

7838

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.2

62.7

699

2605

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

62.5

2625

14814

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

62.2

1894

9923

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.6

62.2

1981

10498

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

62.2

7669

51953

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

62.0

10578

74895

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

9.3

61.7

137

118

CJF15

NOMESCO Finland

Secondary implantation of skleral fixed artificial lens in posterior chamber

97.7

61.6

CGG31

NOMESCO Finland

Posterior corneal lamellar transplantation

37.5

61.5

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.1

61.4

366

955

P20

ICPC

Memory disturbance

1.6

61.3

1617

8159

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

61.2

907

3805

A06AD11

ATC

lactulose; oral

1.5

61.1

2241

12273

R03BB04

ATC

tiotropium bromide; inhalant

1.6

60.8

1747

9014

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

60.8

1217

5663

D82

ICPC

Teeth/gum disease

1.4

60.7

4802

30425

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.4

60.4

313

738

H18.6

ICD-10 Finland

Keratoconus

9.0

60.3

137

123

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

60.3

797

3195

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

60.1

1017

4474

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

60.0

1267

5993

HAHOM

NOMESCO Finland

4.5

59.8

229

412

CKC30

NOMESCO Finland

Cryopexy of detached retina

6.5

59.6

167

208

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

59.3

937

4021

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

9.8

59.2

128

105

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.5

59.2

520

1723

H18.2

ICD-10 Finland

Other corneal oedema

26.9

59.0

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

59.0

2181

11958

M05BA04

ATC

alendronic acid; oral

1.8

58.9

1150

5305

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

58.8

913

3895

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

58.6

8250

56734

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.2

58.6

634

2328

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

4.9

58.5

207

343

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.1

58.4

728

2849

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.2

58.1

647

2409

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

58.0

2441

13763

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.0

58.0

808

3306

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

11.4

57.9

116

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

57.8

1453

7232

I44.1

ICD-10 Finland

Atrioventricular block, second degree

3.7

57.7

268

578

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

57.6

663

2506

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

17.3

57.6

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

57.4

1674

8669

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.3

57.1

565

1988

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

57.1

1151

5365

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

56.8

541

1869

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

56.7

1623

8358

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.7

56.6

1220

5805

I20.01

ICD-10 Finland

Unstable angina

2.7

56.5

408

1210

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

56.4

408

1212

-1

SPAT

2.4

56.3

507

1701

ZXC50

NOMESCO Finland

Cryotherapy

2.5

56.1

470

1517

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.2

56.0

596

2172

C08CA02

ATC

felodipine; oral

1.6

56.0

1449

7266

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

3.5

55.9

281

647

A10BB01

ATC

glibenclamide; oral

2.0

55.6

744

2998

I50.1

ICD-10 Finland

Left ventricular failure

2.1

55.5

662

2542

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

55.4

2440

13876

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

48.2

55.3

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

55.2

996

4476

R33

ICD-10 Finland

Retention of urine

1.7

55.0

1323

6500

CKC20

NOMESCO Finland

Cryopexy of undetached retina

10.5

54.8

114

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

54.6

840

3568

Coronary artery bypass surgery

3.3

54.6

292

706

WX204

NOMESCO Finland

Axillary plexus blockaced

2.4

54.5

518

1788

A98

ICPC

Health maint/preventive medicine

1.4

54.2

16471

125217

B01AB10

ATC

tinzaparin; parenteral

1.8

54.2

1088

5065

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

54.2

838

3567

M25.5

ICD-10 Finland

Pain in joint

1.4

54.0

4014

25095

WZC30

NOMESCO Finland

Teaching

1.5

53.9

2041

11232

C02AC05

ATC

moxonidine; oral

2.0

53.9

720

2898

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

53.6

731

2967

G04CA01

ATC

alfuzosin; oral

1.5

53.4

2000

10979

H33.5

ICD-10 Finland

Other retinal detachments

4.9

53.3

186

304

NG1DA

NOMESCO Finland

X-ray of knees

2.9

53.3

342

941

H30.2

ICD-10 Finland

Posterior cyclitis

11.9

53.2

104

A10BH05

ATC

linagliptin; oral

2.1

53.1

678

2679

R5120

NOMESCO Finland

Preparation of an aid

2.8

53.1

364

1046

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.8

52.8

1067

4975

H33.4

ICD-10 Finland

Traction detachment of retina

15.7

52.8

H18.1

ICD-10 Finland

Bullous keratopathy

26.1

52.6

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.7

52.6

381

1133

R03AC02

ATC

salbutamol; inhalant

1.3

52.5

7886

54395

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

+∞

52.5

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.3

52.5

283

689

C10AA04

ATC

fluvastatin; oral

1.7

52.4

1305

6470

ZXD20

NOMESCO Finland

Day surgery

1.5

52.3

1915

10458

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

52.1

2990

17871

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

52.1

1778

9556

N06AA09

ATC

amitriptyline; systemic

1.6

52.0

1578

8243

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

52.0

691

2776

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

51.8

979

4467

R11

ICD-10 Finland

Nausea and vomiting

1.8

51.8

1007

4639

AN4

Balloon angioplasty and drug eluding stent

2.4

51.7

457

1519

M01AH05

ATC

etoricoxib; oral

1.3

51.7

9263

65267

M17.5

ICD-10 Finland

Other secondary gonarthrosis

3.4

51.5

268

635

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

51.4

2697

15851

C10AX09

ATC

ezetimibe; oral

1.6

51.2

1655

8778

G04BD12

ATC

mirabegron; oral

1.6

51.1

1514

7857

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.0

51.0

221

449

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

4.2

51.0

206

392

EBB10

NOMESCO Finland

Insertion of dental implant

3.4

50.9

264

624

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.2

50.7

571

2137

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.9

50.6

782

3325

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.1

50.3

648

2568

AA1

Conventional CABG

3.7

50.3

237

518

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

9.1

50.3

113

100

CKD50

NOMESCO Finland

Endodiathermy of retina

17.1

50.3

CG2Z4

NOMESCO Finland

Specialised imaging of cornea

27.9

50.1

L03

ICPC

Low back symptom/complaint

1.4

50.0

3270

19979

SPAT1255

SPAT

Intravenous administration of medicine

1.8

49.9

937

4265

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

49.9

843

3702

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

49.8

1450

7490

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

49.6

1130

5458

TK820

NOMESCO Finland

Peritoneal dialysis

12.8

49.6

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

49.6

438

1457

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

7.1

49.6

130

148

E000001

ATC

1.4

49.4

2863

17126

NGC20

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, normal prosthesis

6.5

49.4

137

169

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

5.2

49.4

164

254

N30.0

ICD-10 Finland

Acute cystitis

1.5

49.1

1726

9330

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.4

49.0

433

1439

H57.1

ICD-10 Finland

Ocular pain

2.4

49.0

442

1486

N06AX11

ATC

mirtazapine; oral

1.3

48.8

4479

28842

SPAT1131

SPAT

Colonoscopy

2.2

48.6

544

2028

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

4.9

48.6

169

276

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

3.3

48.5

263

643

WX402

NOMESCO Finland

General anaesthesia

1.4

48.2

2356

13648

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

10.8

48.2

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

48.2

3081

18738

R13

ICD-10 Finland

Dysphagia

1.8

48.0

960

4460

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

47.9

1100

5327

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

10.8

47.8

CG2S4

NOMESCO Finland

Photography of cornea

7.8

47.8

117

120

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

47.7

3511

21847

H52.2

ICD-10 Finland

Astigmatism

3.4

47.6

244

572

SPAT1234

SPAT

Support of social functional capacity

2.0

47.5

631

2534

C10AA03

ATC

pravastatin; oral

1.7

47.5

1056

5067

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

47.4

471

1662

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.6

47.4

230

516

B01AB04

ATC

dalteparin; parenteral

1.9

47.3

716

3025

A10AB06

ATC

insulin glulisine; parenteral

4.0

47.2

201

402

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

47.2

1248

6286

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

47.0

1545

8217

M10.9

ICD-10 Finland

Gout, unspecified

1.7

47.0

974

4575

L57.0

ICD-10 Finland

Actinic keratosis

1.6

46.9

1396

7248

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.5

46.8

395

1280

N06AX21

ATC

duloxetine; oral

1.6

46.7

1412

7357

H05BX01

ATC

cinacalcet; oral

8.1

46.7

112

111

H25.2

ICD-10 Finland

Senile cataract, morgagnian type

6.1

46.6

136

180

J01AA02

ATC

doxycycline; systemic

1.3

46.6

13113

96946

I50

ICD-10 Finland

Heart failure

2.6

46.6

371

1165

-1

NOMESCO Finland

1.3

46.5

4333

27920

XF404

NOMESCO Finland

Ambulatory ECG

1.6

46.4

1252

6338

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

46.2

3737

23582

CHD35

NOMESCO Finland

Laser goniopuncture

7.7

46.1

114

119

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

46.0

1888

10551

ZXD00

NOMESCO Finland

Emergency procedure

2.3

45.8

449

1573

H21.0

ICD-10 Finland

Hyphaema

8.9

45.8

104

V03AE03

ATC

lanthanum carbonate; oral

14.2

45.8

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

45.7

1163

5795

TCG20

NOMESCO Finland

Laser suture lysis in cornea or sclera

40.8

45.6

M01AH02

ATC

rofecoxib; oral

1.4

45.4

2103

12045

3626

FHL

Extracapsular cataract surgery and implantation of an artificial lens

2.8

45.3

321

942

R02

ICPC

Shortness of breath/dyspnoea

1.5

45.3

1589

8581

K78

ICPC

Atrial fibrillation/flutter

1.7

45.2

998

4775

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

45.2

4556

29665

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

45.1

5206

34513

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

11.8

44.9

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.5

44.8

484

7043

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

44.7

622

2545

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.2

44.6

507

1906

L04AX01

ATC

azathioprine; systemic

2.0

44.4

592

2378

M02AA07

ATC

piroxicam; topical

1.3

44.4

5750

38676

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.4

44.3

414

1416

J01EA01

ATC

trimethoprim; systemic

1.3

44.3

3470

21768

CGF10

NOMESCO Finland

Suture of laceration of cornea

22.7

44.2

T84.8

ICD-10 Finland

Other complications of internal orthopaedic prosthetic devices, implants and grafts

8.4

44.1

103

R31

ICD-10 Finland

Unspecified haematuria

1.5

43.9

1571

8520

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

43.9

298

853

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

43.8

1065

5238

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.2

43.8

244

610

-54

ICPC

Repair/fix-suture/cast/prosth device

2.4

43.8

403

1370

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.4

43.8

412

1417

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3031040) Bacteria [#/volume] in Urine by Automated count

19127

110722

1.64

318.33

5.8

4.6

e6/l

1923.9

1455.4

0.40

272

1849

(3000850) Epithelial cells [#/volume] in Urine

7781

36066

1.72

311.77

3.2

2.5

e6/l

5.4

5.3

0.33

6863

31326

(3020682) Albumin/Creatinine [Ratio] in Urine

10910

55341

1.63

309.17

5.1

3.8

mg/mmol

14.1

8.0

18.03

6720

33941

(3026008) Bacteria identified in Urine by Culture

10696

52964

1.67

307.65

3.8

3.2

—

(3025159) Blasts/100 leukocytes in Blood

3713

11744

2.42

307.65

4.0

0.3

0.00

915

3059

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12105

62151

1.64

307.65

3.4

2.6

ug/l

158.2

149.9

1.96

10544

56523

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9095

40941

1.83

307.65

2.5

2.2

mg/l

3.3

3.0

18.07

7576

34367

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

21785

129492

1.73

307.65

8.7

7.2

u/l

81.3

80.0

2.66

20184

121023

(3021601) Nitrite [Presence] in Urine by Test strip

14855

80088

1.63

307.65

6.2

4.9

estimate

0.0

0.21

4688

13682

(3017181) Myelocytes/100 leukocytes in Blood

4036

13205

2.35

307.65

4.0

3.9

0.9

1.0

0.58

1118

3888

(3032080) INR in Blood by Coagulation assay

14600

69179

1.98

307.65

13.1

8.1

inr

1.3

0.13

6160

17944

(3013826) Glucose [Moles/volume] in Serum or Plasma

18275

97867

1.85

307.65

5.5

4.3

mmol/l

7.1

6.8

51.12

17329

91564

(40760892) CBC W Ordered Manual Differential panel - Blood

7546

32054

1.90

307.65

5.4

4.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8711

35835

2.02

307.65

1.9

1.7

pmol/l

19811330.8

28543056.4

0.83

6451

29258

(3035350) Ketones [Presence] in Urine by Test strip

14813

79691

1.64

307.65

4.7

3.7

estimate

0.0

0.50

4695

13457

(40761536) Microorganisms panel - Urine sediment

5034

12526

3.23

307.65

4.9

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6849

15744

3.71

307.65

3.9

3.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11358

50595

1.96

307.65

3.4

2.6

ng/l

1947.0

1369.2

20.67

9694

43106

(3013512) EKG study

11106

49737

1.93

307.65

4.9

3.8

—

(3010421) pH of Blood

1831

4041

3.35

307.65

4.3

3.8

7.4

0.83

1636

3406

(3002179) Metamyelocytes/100 leukocytes in Blood

3802

11837

2.46

307.65

3.9

3.8

0.6

0.7

0.28

864

2767

(3012501) Base excess in Blood by calculation

1667

3507

3.51

307.65

4.3

3.9

mmol/l

2.6

2.7

0.62

1179

2403

(1616796) Gas panel - Central venous blood

1601

3434

3.43

307.65

4.1

3.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

5968

25126

1.85

307.65

3.2

2.2

umol/l

11.8

12.7

14.93

5370

23077

(3021589) Normoblasts [#/volume] in Blood

14516

70847

1.89

307.65

14.5

9.2

e9/l

0.0

0.18

12895

56907

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14133

75337

1.63

307.65

4.9

3.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

3905

12517

2.39

307.65

4.0

0.1

0.74

1062

3589

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5350

21751

1.91

307.65

3.2

2.3

21.5

22.4

4.03

4505

18373

(3041096) Erythrocytes [Presence] in Urine by Automated

9400

39978

1.98

307.65

4.7

3.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16171

86985

1.70

307.65

8.0

5.9

mmol/l

1.2

4.12

12039

73371

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13597

64173

1.93

307.65

4.9

3.4

ng/l

70.2

61.2

0.23

11064

46161

(3026782) Osmolality of Urine

7554

33466

1.80

307.65

3.4

2.6

mosm/kgh2o

516.3

553.3

43.24

6575

28112

(3028271) Lactate [Moles/volume] in Capillary blood

1208

2419

3.64

307.65

2.1

1.8

mmol/l

1.6

1.8

5.05

1188

2347

(3009261) Glucose [Presence] in Urine by Test strip

14968

81048

1.62

307.65

4.8

3.8

estimate

0.0

0.72

4525

13406

(3027315) Oxygen [Partial pressure] in Blood

1669

3529

3.49

307.65

4.4

3.9

kpa

8.4

8.5

0.07

1634

3426

(3029937) Albumin [Presence] in Urine by Test strip

9416

43416

1.79

307.65

5.0

4.2

estimate

0.0

0.24

4465

13051

(40767503) Oxygen content in Capillary blood by calculation

1601

3271

3.61

307.65

2.9

2.4

15.9

16.2

2.14

865

1673

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12064

60446

1.70

307.65

5.1

4.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

19817

113917

1.71

307.65

5.6

4.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5662

23160

1.90

307.65

3.1

2.2

g/l

2.3

7.17

5087

21240

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4847

13510

2.84

307.65

4.3

3.6

mmol/l

1.2

4.34

4065

11722

(3013707) Erythrocyte sedimentation rate by Westergren method

20675

121319

1.69

307.65

5.4

4.0

mm/h

15.5

13.3

58.93

18540

111020

(3013290) Carbon dioxide [Partial pressure] in Blood

1667

3509

3.51

307.65

4.3

3.9

kpa

5.0

0.20

1632

3407

(3019309) Folate [Moles/volume] in Red Blood Cells

7620

33597

1.82

307.65

2.1

1.7

nmol/l

1290.4

1157.6

22.67

5313

24890

(3023368) Bacteria identified in Blood by Culture

9880

46808

1.74

307.65

4.9

4.1

—

(42870588) Differential panel, method unspecified - Blood

10925

55727

1.62

300.25

6.4

5.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

24348

151390

1.80

295.03

7.9

6.0

mmol/mol

42.5

40.2

195.27

21656

137903

(3026250) Tacrolimus [Mass/volume] in Blood

240

37.23

293.66

41.7

18.0

ug/l

7.3

6.9

0.57

216

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10259

51738

1.62

293.53

3.0

2.5

u/l

58.4

59.5

0.55

9220

47262

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

14514

79628

1.57

289.77

6.8

5.3

mmol/l

1.2

0.12

12662

71549

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

25487

160980

1.89

288.78

21.1

14.4

mg/l

23.4

26.0

27.82

21841

127663

(3012516) Albumin [Mass/volume] in Urine

10347

52512

1.61

286.77

3.9

3.1

mg/l

302.7

394.6

1.45

6355

32444

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

15628

87360

1.57

286.04

6.0

umol/l

11.6

11.7

0.56

14581

82613

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1702

4545

2.75

285.33

2.1

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2920

10096

2.16

280.30

4.4

3.3

kpa

5.1

5.2

1.78

2695

9297

(3009343) pH of Capillary blood

2888

9974

2.16

277.90

4.3

3.3

7.4

0.82

665

1210

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12531

67056

1.56

273.13

2.5

2.1

nmol/l

79.5

1471.4

0.50

10730

58906

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2803

9629

2.17

273.08

4.3

3.3

mmol/l

1.9

0.13

2064

7244

(3042936) Bacteria identified in Isolate by Culture

5237

22435

1.79

270.36

2.4

1.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

26514

170477

2.01

269.35

24.4

16.6

mmol/l

139.4

139.7

56.89

25727

165757

(3021901) Oxygen saturation in Capillary blood

1237

2851

3.16

267.61

3.0

2.7

—

(3023520) Reticulocytes [#/volume] in Blood

3731

14388

1.96

266.47

3.2

2.5

e9/l

68.4

68.5

0.03

2991

10687

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10142

51934

1.58

265.37

2.3

2.1

u/l

206.0

213.1

0.31

9258

48370

(3023103) Potassium [Moles/volume] in Serum or Plasma

26536

170838

2.00

264.95

24.7

16.8

mmol/l

4.0

84.70

25711

165826

(3022806) Fractional oxyhemoglobin in Capillary blood

976

1953

3.62

261.71

2.0

1.8

89.4

89.2

0.45

968

1913

(1761868) Lipid panel - Serum or Plasma

9569

48495

1.59

260.43

3.9

3.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1387

3477

2.91

260.27

3.1

2.9

kpa

8.1

8.0

1.52

1304

3239

(3024561) Albumin [Mass/volume] in Serum or Plasma

13621

74790

1.54

260.02

5.3

4.3

g/l

34.3

35.1

44.30

12326

68819

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4936

21059

1.79

256.90

7.7

4.3

mmol/l

1.1

1.0

23.58

4523

19351

(3009508) Creatinine [Moles/volume] in Urine

10394

53864

1.57

255.83

3.8

3.0

mmol/l

6.7

7.4

44.79

8106

44597

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

20231

121542

1.57

253.06

4.5

4.0

pmol/l

15.2

15.0

45.32

17347

108862

(3006504) Eosinophils/100 leukocytes in Blood

13596

74995

1.53

250.77

6.8

5.8

2.9

0.16

12510

69221

(3019069) Monocytes/100 leukocytes in Blood

13654

75426

1.52

249.73

7.1

6.1

8.9

8.7

8.88

12632

69859

(3021960) Folate [Moles/volume] in Serum or Plasma

8285

40920

1.60

248.66

1.6

1.5

nmol/l

20.3

20.6

0.81

6662

34687

(3022096) Basophils/100 leukocytes in Blood

13271

72940

1.52

247.83

6.9

5.8

0.7

0.98

12229

67363

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1469

3946

2.72

242.76

3.1

2.9

mmol/l

24.8

25.0

0.91

1319

3489

(3002030) Lymphocytes/100 leukocytes in Blood

13847

77030

1.51

242.31

7.0

5.9

25.6

27.3

56.57

12725

70936

(3006315) Basophils [#/volume] in Blood

14321

80519

1.50

235.63

6.5

5.6

e9/l

0.0

0.20

12587

67876

(3002582) Erythrocytes [#/volume] in Urine

10057

52447

1.54

235.53

3.9

3.2

e6/l

130.4

90.3

0.93

8290

39544

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

24205

152805

1.68

234.13

20.0

13.8

ml/min/173m2

71.8

77.0

266.27

21387

124209

(3013115) Eosinophils [#/volume] in Blood

14661

83054

1.50

230.56

6.6

5.8

e9/l

0.2

1.15

12945

71243

(3001604) Monocytes [#/volume] in Blood

14222

80137

1.50

228.92

6.5

5.6

e9/l

0.6

25.23

12526

67487

(3027945) Reticulocytes/100 erythrocytes in Blood

4543

19510

1.77

228.57

2.8

2.4

1.8

3.31

3872

17100

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5896

27226

1.67

228.14

2.0

1.8

—

(3018418) pH of Serum or Plasma

10017

52494

1.53

227.34

4.9

3.7

7.4

0.65

3410

8919

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23519

147797

1.63

224.97

5.5

4.8

mu/l

2.1

2.2

0.21

20389

133175

(3018010) Neutrophils/100 leukocytes in Blood

13551

75788

1.49

224.61

6.6

5.7

59.1

57.6

36.97

12476

70137

(3019198) Lymphocytes [#/volume] in Blood

14479

82174

1.49

222.37

6.6

5.6

e9/l

1.8

1.9

3.22

12891

70667

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1288

3442

2.72

214.49

3.7

2.4

mg/l

1.8

1.5

22.06

1125

3087

(3030467) Casts [#/volume] in Urine by Automated count

9290

48399

1.52

213.24

3.7

3.1

e6/l

0.5

0.4

1.06

7563

35957

(40761511) CBC panel - Blood by Automated count

25700

166002

1.75

210.26

21.9

13.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

241

135

12.73

202.25

27.2

13.2

ug/l

102.4

103.7

0.07

203

116

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3318

13406

1.85

202.02

2.1

2.3

nmol/l

359.9

381.3

6.23

3030

12264

(3007853) Bacteria identified in Skin by Aerobe culture

4231

18446

1.73

199.43

2.0

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5614

26536

1.61

193.91

3.2

2.9

mmol/l

0.8

1.09

5153

24472

(3044889) 12 lead EKG panel

19335

117832

1.47

193.00

5.0

3.8

—

(3018095) Leukocytes [#/volume] in Urine

11050

60590

1.47

192.06

4.4

3.6

e6/l

137.0

111.6

1.66

8736

42497

(3013650) Neutrophils [#/volume] in Blood by Automated count

15983

93999

1.45

191.68

9.2

8.9

e9/l

4.4

4.2

25.92

14219

80625

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2602

9979

1.93

184.84

5.5

6.4

mmol/l

24.8

24.9

1.11

2568

9873

(3020564) Creatinine [Moles/volume] in Serum or Plasma

26259

171870

1.75

183.11

24.5

17.1

umol/l

86.5

78.3

141.57

26248

171794

(3015377) Calcium [Moles/volume] in Serum or Plasma

10693

58696

1.45

181.92

3.3

mmol/l

2.3

2.4

6.45

9088

50230

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1034

2682

2.79

181.64

3.9

2.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3332

13944

1.78

179.51

10.0

4.9

mmol/l

12.0

10.0

36.79

3160

13109

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4320

19520

1.66

176.45

3.7

4.0

u/l

246.2

244.4

0.19

4020

18376

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

12751

72799

1.42

172.34

2.2

2.0

pmol/l

94.7

94.8

0.06

6533

36638

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

26186

171822

1.71

170.76

13.3

10.5

u/l

24.5

25.6

13.04

24631

164686

(3004588) Protein electrophoresis panel - Serum or Plasma

2972

12281

1.79

166.26

2.4

2.3

—

(3007461) Platelets [#/volume] in Blood

26778

177402

1.75

157.80

31.1

21.4

e9/l

244.5

248.0

13.86

26013

171431

(3035941) MCH [Entitic mass]

26779

177453

1.75

156.87

30.9

21.3

30.4

0.43

26180

174139

(3010813) Leukocytes [#/volume] in Blood

26784

177496

1.75

156.86

31.1

21.4

e9/l

7.0

6.7

29.34

25925

170824

(3024731) MCV [Entitic volume]

26780

177475

1.75

156.57

30.9

21.3

91.9

91.4

43.27

26186

174153

(3000963) Hemoglobin [Mass/volume] in Blood

26783

177501

1.75

156.56

31.3

21.5

g/l

131.0

134.6

269.67

26201

174187

(3026361) Erythrocytes [#/volume] in Blood

26780

177481

1.75

156.44

31.0

21.4

e12/l

4.3

4.5

243.46

25923

170757

(36304419) Bacteria [Presence] in Urine

8685

46861

1.44

155.51

3.6

3.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3387

14798

1.70

155.32

2.6

2.5

g/l

66.0

66.4

1.87

3004

13302

(3026493) Urate [Moles/volume] in Serum or Plasma

8159

43656

1.45

152.01

3.2

2.5

umol/l

6318.9

5403.9

0.85

6716

37041

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

796

1982

2.89

150.30

1.6

1.5

60.8

58.8

0.61

465

1253

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

585

1204

3.49

150.18

1.6

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1238

3852

2.33

149.88

2.7

2.1

g/l

126.8

128.9

2.02

1038

2671

(3034891) Synovial lining cells/100 cells in Synovial fluid

430

708

4.35

148.82

1.6

1.4

4.0

3.4

0.35

149

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1845

6760

1.99

148.20

2.0

1.9

ug/l

2.3

2.2

0.05

1595

5937

(3003338) MCHC [Mass/volume]

16610

133433

0.73

140.08

26.4

19.3

g/l

330.6

331.8

53.56

16421

132263

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

23421

151359

1.47

139.30

4.7

4.0

mmol/l

1.3

0.75

20032

135662

(3022217) INR in Platelet poor plasma by Coagulation assay

4702

22872

1.54

137.90

28.2

24.2

inr

1.5

1.3

5.38

772

2778

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2328

9436

1.81

137.49

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2809

12051

1.72

136.53

1.8

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

527

1083

3.49

135.58

1.9

2.0

ug/l

3.0

3.8

1.82

479

944

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

24823

162543

1.51

135.20

5.9

5.2

mmol/l

2.5

2.7

213.11

21465

147480

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

24390

159147

1.49

134.85

5.6

4.8

mmol/l

6.3

6.0

95.49

20794

143314

(3021788) Differential panel - Synovial fluid

1007

2995

2.43

134.47

1.6

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2621

11086

1.74

133.84

3.2

2.6

g/l

10.5

10.6

0.45

2354

10072

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6472

33813

1.46

133.52

1.8

1.6

mg/l

1.3

1.4

0.59

5019

26182

(3025577) Chromium [Mass/volume] in Blood

516

1058

3.50

133.19

1.9

2.1

ug/l

2.0

2.4

2.06

444

866

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

24099

156992

1.48

132.67

5.4

4.5

mmol/l

1.5

17.18

20775

142111

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

639

1507

3.05

132.41

1.7

1.5

30.1

28.6

0.42

349

952

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

24285

158499

1.48

131.72

5.4

4.6

mmol/l

4.4

4.6

199.81

21086

144530

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

662

1613

2.95

129.76

1.6

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2881

12631

1.68

128.90

4.7

3.1

ng/l

112.7

83.4

27.89

2274

10750

(40760888) Immunoglobulin light chains.free panel - Serum

1241

4145

2.17

126.75

3.2

3.3

—

(3042631) Mycobacterium sp identified in Specimen

847

2385

2.56

126.68

2.9

2.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2098

8637

1.77

116.93

2.2

1.9

g/l

1.3

1.4

0.29

1869

7747

(3002385) Erythrocyte distribution width [Ratio]

20558

131224

1.36

115.71

23.9

17.9

14.0

13.8

53.69

20054

128182

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1199

4094

2.12

115.71

2.8

2.2

ug/min

167.2

106.5

2.72

681

2299

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1485

5510

1.96

114.37

3.1

3.2

ratio

2.8

6.3

1.18

107

421

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

464

982

3.38

114.25

1.5

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1982

8087

1.79

113.72

4.8

3.0

mmol/l

25.2

25.3

0.52

1943

7841

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1663

6462

1.87

111.55

2.1

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1512

5699

1.93

111.17

3.1

3.2

mg/l

62.5

78.3

0.53

1024

4698

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1884

7624

1.80

111.01

5.3

3.6

47.1

47.5

0.25

1864

7536

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1509

5687

1.93

110.99

3.1

3.2

mg/l

46.1

45.4

0.04

1023

4694

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1558

5957

1.90

109.74

2.0

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

421

858

3.51

109.66

1.6

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

951

3021

2.27

109.41

1.3

1.2

titre

78.8

170.6

1.34

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

861

2619

2.37

109.31

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

418

854

3.50

108.49

1.6

1.5

—

(40768797) Stomach Pathology biopsy report

4542

22983

1.47

107.37

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5881

31260

1.41

106.70

1.4

1.2

u/ml

1.6

1.8

0.34

1725

7688

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1856

7568

1.79

106.50

1.8

1.6

g/l

1.6

1.34

1570

6405

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1067

3598

2.14

106.18

1.6

1.4

—

(3042733) HLA Ab [Presence] in Serum

150

115

9.28

104.46

5.5

3.7

—

(3012544) pH of Venous blood

3356

16050

1.54

103.61

5.0

3.2

7.4

0.29

(3016750) Collection duration of Urine

423

900

3.36

103.34

2.4

1.8

min

501.9

496.2

0.51

269

644

(3008037) Lactate [Moles/volume] in Venous blood

1100

3796

2.09

103.14

4.1

3.0

mmol/l

1.6

0.04

1073

3723

(3022313) Gas panel - Capillary blood

1791

7312

1.78

102.22

4.8

3.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4897

25369

1.44

101.77

2.0

1.8

30.1

29.7

4.07

4717

24632

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

712

2059

2.48

100.73

1.6

1.4

—

(3004775) Volume in Urine collected for unspecified duration

528

1307

2.89

100.65

2.5

2.0

727.3

647.0

3.02

317

840

(3025941) Bacteria identified in Stool by Culture

1899

7922

1.75

100.63

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1022

3480

2.12

99.15

1.6

1.4

—

(3000012) Reticulocyte production index

420

916

3.28

98.78

1.7

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15796

98115

1.30

98.49

3.6

3.0

u/l

57.0

52.4

5.37

14011

89652

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7847

44220

1.35

98.22

1.7

1.6

mmol/l

1.3

0.49

5380

36968

(3002032) Base excess in Venous blood by calculation

3242

15574

1.53

97.68

5.2

3.2

mmol/l

1.9

2.0

0.51

2653

12705

(3038515) Glucose [Moles/volume] in Venous blood

1040

3612

2.08

95.83

4.3

3.1

mmol/l

7.8

7.6

1.46

1015

3547

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3238

15624

1.52

95.43

5.1

3.2

kpa

5.8

0.37

3168

15143

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1082

3864

2.02

92.48

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

1241

4663

1.92

91.79

5.2

4.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1247

4754

1.89

88.27

1.4

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

690

2091

2.37

88.26

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2976

14386

1.52

86.41

2.6

2.2

ug/l

5.7

6.2

0.74

2437

12271

(3000330) Specific gravity of Urine by Test strip

2006

8847

1.65

86.18

4.6

3.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

2723

12972

1.54

84.48

4.1

2.7

kpa

4.6

4.5

1.34

2656

12523

(3033705) Calcium.ionized [Moles/volume] in Venous blood

683

2114

2.32

83.33

2.8

2.3

—

(3035285) Chloride [Moles/volume] in Venous blood

688

2142

2.30

82.82

2.8

2.2

mmol/l

105.8

105.5

0.88

681

2127

(3041354) Potassium [Moles/volume] in Venous blood

688

2142

2.30

82.82

2.8

2.2

mmol/l

4.1

1.76

681

2128

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

739

2376

2.23

82.53

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

10093

60067

1.29

81.72

5.6

5.3

ug/l

3.8

4.0

0.20

8619

53460

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1525

6334

1.74

81.61

5.4

3.6

mmol/l

24.7

25.0

3.41

1390

5804

(3004451) EKG impression Narrative

346

760

3.25

80.54

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

684

2157

2.27

79.94

1.5

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

101

79.73

79.55

5.5

2.2

—

(3019225) pH of Specimen

3427

17328

1.45

79.13

6.1

3.8

—

(3012565) Volume of 24 hour Urine

339

744

3.25

79.02

2.2

2.1

1814.3

1933.9

1.19

276

646

(3037522) Nuclear Ab [Titer] in Serum

3856

19953

1.42

78.54

1.4

1.3

titre

527.1

539.4

0.15

913

4308

(3007164) IgA [Mass/volume] in Serum or Plasma

5045

27352

1.37

77.98

1.7

1.4

g/l

2.7

2.6

1.83

3074

15150

(3022145) Colonoscopy Study observation

3583

18394

1.43

76.03

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1964

8889

1.60

75.74

3.5

2.7

e6/l

0.3

0.64

1932

8670

(3044640) Blood type and Crossmatch panel - Blood

8849

52175

1.29

75.44

2.8

2.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1621

7003

1.68

75.07

1.5

u/ml

24.2

16.2

0.66

173

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3125

15697

1.46

74.36

2.1

g/l

0.2

4.64

2842

14502

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3714

19277

1.42

73.99

1.8

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2173

10152

1.56

73.10

4.2

2.8

g/l

125.1

129.4

15.65

2113

9935

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

780

2708

2.07

71.83

1.5

1.3

—

(40768446) Kidney Pathology biopsy report

199

319

4.44

71.32

1.8

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1454

6193

1.70

70.91

1.8

u/l

38.4

39.2

0.66

1266

5369

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

340

802

3.02

70.53

4.1

3.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

848

3062

1.99

70.17

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1564

6846

1.65

68.76

5.0

4.4

1.5

1.6

6.24

1495

6413

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2633

12988

1.48

68.40

3.2

2.7

ml/min/173m2

54.1

64.1

34.11

1191

5101

(21494755) Public health laboratory ask at order entry panel

610

8725

0.48

67.62

1.3

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1283

5372

1.72

66.50

1.8

1.6

titre

229.5

263.6

0.24

235

(3040151) Glucose [Moles/volume] in Capillary blood

596

1921

2.22

66.18

7.2

11.6

mmol/l

7.4

7.5

0.05

508

1587

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

710

2476

2.06

64.61

6.7

2.2

iu/ml

7471.8

841.1

0.72

133

249

(3007930) Methemoglobin/Hemoglobin.total in Blood

1526

6747

1.63

64.41

5.0

4.5

0.8

0.9

3.02

1455

6316

(3000494) Fungus identified in Specimen by Culture

3535

18738

1.38

61.33

1.5

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3631

19374

1.37

60.42

1.9

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

702

2509

2.00

59.76

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4685

26040

1.33

59.49

1.3

iu/ml

41.6

40.3

0.18

1552

8046

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1379

6076

1.64

58.92

2.6

—

(3037756) Immunofixation for Serum or Plasma

960

3828

1.80

58.76

1.6

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1103

4586

1.73

58.54

1.5

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5837

33675

1.28

55.70

3.0

3.1

mmol/l

2.5

4.49

5175

29137

(3002256) Pathology report gross observation

4005

22044

1.33

53.87

1.4

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

724

2718

1.91

53.53

3.2

1.3

1.6

1.17

558

2114

(3027456) Digoxin [Moles/volume] in Serum or Plasma

864

3436

1.80

53.34

3.2

3.1

nmol/l

0.8

1.40

651

2677

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1241

5462

1.64

53.18

2.8

2.5

u/ml

0.4

0.48

748

3017

(3029634) Reagin Ab [Titer] in Serum by VDRL

428

1318

2.32

52.92

1.9

titre

3.9

6.0

—

(3003181) Sodium [Moles/volume] in Urine

793

3085

1.84

52.55

1.4

1.3

mmol/l

62.2

62.6

0.11

644

2459

(3037121) Protein [Mass/volume] in Urine

1239

5543

1.61

49.68

3.7

2.9

g/l

0.5

0.3

4.04

579

2289

(3019060) Gas panel - Arterial blood

2245

11390

1.43

49.59

4.4

4.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

440

1416

2.22

49.13

3.6

2.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

927

3865

1.72

48.67

1.8

1.9

mg/l

10.3

11.6

3.80

848

3574

(3003694) ABO and Rh group [Type] in Blood

6883

41035

1.24

48.67

1.6

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1637

7840

1.51

48.55

3.3

2.4

0.7

4.07

1569

7496

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2739

14439

1.38

48.39

3.2

2.4

ng/l

236.6

194.2

4.51

2521

13119

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

535

1871

2.04

48.38

3.3

1.5

u/ml

369.5

6421.5

0.76

123

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

110

147

5.31

48.35

6.6

3.5

ug/min

50.9

49.4

0.07

113

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1663

8001

1.50

48.25

3.3

2.5

1.2

2.53

1653

7964

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

441

1435

2.19

47.95

1.1

iu/ml

1.7

2.2

0.34

(40768804) Tissue Pathology biopsy report

10792

67461

1.21

47.92

2.3

2.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1120

4935

1.63

47.74

1.6

1.4

ug/g

264.2

266.2

0.12

690

2911

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1280

5826

1.58

47.74

2.1

ug/l

668.0

554.0

0.29

1208

5475

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4345

24580

1.29

47.32

1.3

1.2

u/ml

17.0

14.3

0.68

1615

8727

(3024471) HLA-A [Type]

127

198

4.56

47.18

1.0

—

(3017569) Oxygen content in Arterial blood

280

746

2.67

46.85

2.4

2.2

—

(3024932) HLA-DR beta [Type]

123

188

4.65

46.76

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

850

9859

0.60

45.41

1.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

13.66

45.39

7.4

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

113

166

4.83

44.93

3.4

1.8

mg/l

84.3

52.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

288

802

2.56

44.22

2.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

279

765

2.60

44.18

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8220

50402

1.21

43.36

3.2

3.1

u/l

36.5

35.2

0.22

7531

47487

(4146454)

540

1981

1.95

42.78

3.4

2.6

—

(3010503) CD19 cells [#/volume] in Blood

291

842

2.46

41.33

2.1

2.2

e9/l

0.6

0.3

0.38

284

809

(3020876) Protein [Mass/time] in 24 hour Urine

416

1414

2.10

40.62

2.1

1.8

g/24h

0.3

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

534

1993

1.91

40.25

6.5

5.4

mg/l

12.1

12.0

0.23

483

1806

(3016502) Oxygen saturation in Arterial blood

3198

17711

1.31

40.25

6.3

6.8

95.1

95.5

2.22

3074

17055

(3009542) Hematocrit [Volume Fraction] of Blood

21193

141972

1.20

40.07

19.7

16.1

37.3

39.3

74.34

10934

94922

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

285

833

2.44

39.65

1.2

1.1

u/l

85.6

90.5

0.41

228

643

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

285

835

2.43

39.45

1.2

1.1

u/l

24.2

29.8

0.84

223

615

(3023419) Bacteria identified in Sputum by Culture

562

2155

1.86

39.04

2.7

2.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2002

10419

1.39

37.86

1.8

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

581

2281

1.82

37.47

1.7

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

575

2262

1.82

36.85

1.7

1.2

u/ml

13.6

18.8

0.58

(3049717) Cytology report of Urine Cyto stain

1496

7430

1.45

36.80

2.7

2.8

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

520

1990

1.87

36.37

1.5

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

173

408

3.01

36.16

1.2

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

3027

16898

1.30

35.65

2.2

2.1

ug/g

161.5

141.9

1.11

2210

13041

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1848

9587

1.39

35.56

2.6

2.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

512

1969

1.86

35.28

1.5

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

517

1996

1.85

35.20

1.5

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

884

3969

1.59

34.89

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1205

5796

1.49

34.86

1.3

1.2

u/ml

1.5

0.8

0.71

544

(3019977) pH of Arterial blood

298

944

2.25

34.70

2.5

2.7

7.4

0.15

175

316

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

524

2043

1.83

34.59

1.5

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

961

4416

1.56

34.35

1.6

1.5

g/l

0.2

0.11

906

4143

(3014576) Chloride [Moles/volume] in Serum or Plasma

3776

21767

1.26

34.31

6.3

mmol/l

104.1

104.3

1.91

3665

21272

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

509

1975

1.84

34.12

1.5

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2023

10724

1.36

34.03

6.7

6.3

mmol/l

24.6

24.7

1.00

1882

9991

(3005988) Vibrio sp identified in Specimen by Organism specific culture

509

1977

1.84

34.01

1.5

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

203

542

2.66

33.99

1.9

—

(3045414) Leukocytes [Presence] in Urine

1453

7291

1.43

33.78

2.1

1.9

—

(3011412) CD3 cells [#/volume] in Blood

372

1303

2.03

33.64

2.0

2.1

e9/l

1.1

0.23

245

807

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

185

473

2.78

33.60

2.0

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

777

3413

1.63

33.55

1.5

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

313

1027

2.17

33.51

1.5

1.3

—

(3008295) Osmolality of Serum or Plasma

436

1619

1.92

33.44

1.5

1.3

mosm/kgh2o

277.0

277.6

0.17

350

1230

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

977

4540

1.54

33.23

1.6

1.5

g/l

1.2

1.21

921

4284

(3020961) Endomysium IgA Ab [Titer] in Serum

1259

6173

1.46

33.08

1.1

titre

162.9

226.4

0.46

149

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

512

2012

1.82

32.97

1.7

1.2

u/ml

107.1

117.7

1.44

132

453

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

306

1010

2.16

32.30

1.5

1.3

—

(3022621) pH of Urine by Test strip

2048

10999

1.34

31.58

3.9

2.9

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

146

338

3.07

31.55

2.6

2.5

mmol/l

7.6

0.00

196

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

244

739

2.35

31.54

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

244

739

2.35

31.54

1.5

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3474

20014

1.26

31.52

6.2

6.5

kpa

5.1

1.41

3302

19049

(3027801) Oxygen [Partial pressure] in Arterial blood

3472

20002

1.26

31.51

6.2

6.5

kpa

11.7

12.2

8.55

3298

19032

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

967

4537

1.53

31.48

1.9

1.7

—

(40762365) Oxygen content in Arterial blood by calculation

126

267

3.35

31.32

2.0

3.2

ml/dl

14.7

0.02

113

253

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

530

6299

0.59

31.07

1.5

—

(3014271) Vancomycin [Susceptibility]

292

963

2.16

30.91

3.3

2.9

—

(3045424) Erythrocytes [Presence] in Urine

609

2569

1.69

30.73

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

928

4339

1.53

30.70

1.8

1.5

iu/ml

12.6

9.6

0.12

189

1012

(3020650) Glucose [Presence] in Urine

135

303

3.16

30.69

1.4

1.5

—

(3044927) Protein electrophoresis panel - Urine

455

1763

1.84

30.69

1.2

—

(3003396) Base excess in Arterial blood by calculation

3466

20036

1.25

30.47

6.2

6.4

mmol/l

1.2

1.1

0.42

2666

15882

(3020891) Body temperature

1377

6971

1.42

30.46

4.8

4.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12713

82618

1.16

30.41

2.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

613

2611

1.68

29.85

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

372

1362

1.95

29.79

1.2

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

198

559

2.52

29.76

1.3

1.4

2.1

2.7

0.58

162

473

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1700

8953

1.37

29.73

3.1

3.3

pmol/l

4.3

4.4

5.92

1488

7854

(3005322) IgE [Units/volume] in Serum or Plasma

1604

8389

1.37

29.28

1.3

u/ml

262.5

253.8

0.13

1456

7719

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

824

3801

1.55

28.99

3.2

3.3

u/ml

718.3

1053.5

0.52

741

3452

(3017143) Hepatitis C virus Ab [Presence] in Serum

2398

13345

1.30

28.61

1.8

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

1209

6075

1.43

27.87

3.7

3.8

mmol/l

1.4

0.16

1173

5974

(40768443) Skin Pathology biopsy report

1474

7678

1.38

27.57

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

156

408

2.72

27.28

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

211

640

2.34

27.26

1.4

65.8

63.7

0.35

165

534

(4035726)

2741

15624

1.27

26.96

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

473

1932

1.75

26.85

1.4

1.1

u/ml

299.8

270.6

1.37

299

1145

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

498

2068

1.72

26.67

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3631

21403

1.23

26.44

5.4

4.7

34.1

32.6

12.71

2349

13672

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6369

39571

1.18

26.30

2.8

2.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

295

1041

2.02

26.27

1.4

1.6

u/l

8.6

6.1

1.20

122

506

(3017732) Neutrophils [#/volume] in Blood

1952

10716

1.31

25.70

3.1

3.0

e9/l

4.2

4.1

0.86

1279

7891

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

284

1002

2.02

25.33

1.9

15.4

15.2

0.06

437

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

682

3113

1.56

25.18

3.9

1.4

nmol/l

0.8

0.06

541

2579

(1175426) CD3 cells/100 lymphocytes in Blood

288

1025

2.00

25.08

1.9

2.0

70.9

71.6

0.29

278

975

(3014148) Varicella zoster virus Ab [Titer] in Serum

301

1090

1.96

24.97

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.76

24.95

2.4

3.7

—

(3044941) Cell count panel - Synovial fluid

604

2693

1.60

24.64

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

106

236

3.19

24.52

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2814

16277

1.25

24.28

6.8

7.1

g/l

118.2

121.3

12.47

2713

15704

(3026389) Candida sp identified in Specimen by Organism specific culture

517

2227

1.66

24.21

1.5

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

110

253

3.09

24.15

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

433

1782

1.73

24.00

1.2

u/l

56.1

64.5

1.28

274

1202

(3003434) Protein [Mass/volume] in Pleural fluid

555

2444

1.62

23.84

1.4

1.5

g/l

29.8

33.9

10.94

502

2203

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

324

1229

1.88

23.48

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

272

973

1.99

23.40

2.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

374

1487

1.79

23.34

1.4

g/l

6.6

6.9

0.72

208

1053

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2540

14587

1.25

23.30

1.7

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

373

1487

1.79

23.07

1.4

g/l

0.4

1.17

206

1058

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

275

993

1.97

23.05

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

373

1488

1.78

23.02

1.4

g/l

2.7

3.0

1.81

204

1054

(4062490)

371

1480

1.78

22.90

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

864

4231

1.46

22.89

1.7

1.6

e6/l

15849.1

13518.9

0.59

651

3002

(21494815) CD4 cells/100 lymphocytes in Specimen

305

1148

1.89

22.65

1.9

2.0

38.7

41.0

0.32

130

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

359

1423

1.80

22.64

2.0

2.2

u/field

2.8

2.5

0.24

121

589

(3017354) Segmented neutrophils/100 leukocytes in Blood

402

1653

1.73

22.38

3.2

3.1

63.0

58.5

3.24

232

1065

(3014111) Lactate [Moles/volume] in Serum or Plasma

2657

15406

1.24

22.35

5.8

6.2

mmol/l

1.4

0.06

2559

14827

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

912

4534

1.44

22.32

1.5

1.4

iu/ml

21.6

13.8

0.50

114

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1335

7094

1.35

21.99

2.3

2.2

g/l

7.6

7.5

1.19

875

5337

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1331

7075

1.35

21.88

2.3

2.2

g/l

3.8

3.9

0.39

831

5132

(3000919) Neutrophils/100 leukocytes in Pleural fluid

167

505

2.35

21.84

1.3

1.4

21.0

19.8

0.23

152

454

(3036670) Protein [Mass/volume] in Synovial fluid

169

514

2.34

21.82

1.3

g/l

39.9

39.6

0.06

262

(40761535) Cells panel - Urine sediment

2564

14846

1.24

21.82

4.2

3.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1333

7091

1.35

21.80

2.3

2.2

—

(3006270) Folate [Moles/volume] in Blood

336

1321

1.81

21.79

1.2

nmol/l

314.8

347.9

1.63

248

1074

(3023183) Ammonium ion [Moles/volume] in Plasma

705

3354

1.50

21.59

2.4

2.3

umol/l

33.7

34.1

0.08

565

2794

(46235355) HIV 1 and 2 tests - Meaningful Use set

2844

16671

1.23

21.58

1.8

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

435

1848

1.68

21.53

3.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

174

544

2.27

21.12

2.4

1.3

mg/l

76.8

951.6

0.82

109

363

(3000991) Gas panel - Venous blood

2484

14386

1.24

21.07

7.8

7.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

625

2925

1.52

20.70

1.3

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

449

5030

0.63

20.63

1.6

1.7

—

(3034770) Mitochondria Ab [Titer] in Serum

799

3944

1.45

20.34

1.2

titre

808.6

964.9

0.31

130

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

300

1168

1.83

20.12

1.6

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

794

3951

1.43

19.38

1.2

titre

113.4

141.6

0.57

313

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3238

19423

1.20

19.36

3.7

3.9

ug/l

25.5

28.8

0.22

2646

15967

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

485

2184

1.58

19.10

2.1

2.0

mg/l

26.3

27.2

0.13

120

592

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

6.53

18.85

10.0

13.8

e6/l

104.4

153.9

0.38

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1240

6682

1.33

18.60

2.3

2.2

g/l

10.2

10.3

0.30

1005

5558

(3051593) INR in Capillary blood by Coagulation assay

228

834

1.94

18.53

14.7

9.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

244

2.82

18.39

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

139

423

2.33

18.02

2.9

2.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

133

3.52

17.87

1.1

iu/ml

8.4

22.8

1.50

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

181

621

2.07

17.58

1.2

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

259

2.71

17.49

2.6

2.5

—

(3013637) Mi-2 Ab [Presence] in Serum

124

368

2.39

17.02

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

124

368

2.39

17.02

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

124

368

2.39

17.02

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

124

368

2.39

17.02

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

219

815

1.91

16.98

2.3

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

190

679

1.99

16.56

1.2

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

138

435

2.25

16.56

1.2

30.8

23.4

0.42

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.01

16.47

5.4

6.2

umol/l

436.2

392.6

0.29

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

8.95

16.42

8.7

10.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

209

776

1.91

16.33

1.8

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

209

776

1.91

16.33

1.8

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

209

776

1.91

16.33

1.8

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

214

2.82

16.15

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

870

8233

0.74

16.03

1.2

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

208

777

1.90

15.98

1.8

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

274

1116

1.75

15.94

1.2

1.3

mmol/l

2.2

2.3

0.22

254

1035

(3017704) Immunofixation for Urine

238

930

1.82

15.90

1.3

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

759

3885

1.39

15.87

2.6

2.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

311

1315

1.68

15.82

1.7

titre

2468.6

2340.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

197

725

1.93

15.82

2.4

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

409

1855

1.57

15.72

1.3

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

3.80

15.72

1.5

1.7

mg/l

1.6

0.04

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

107

3.64

15.70

1.5

1.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

12.24

15.61

3.6

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

789

4078

1.38

15.57

2.3

2.1

g/l

3.7

0.01

746

3871

(3035880) pH of Pleural fluid

250

1002

1.77

15.39

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

642

3211

1.42

15.33

1.2

u/ml

8.6

15.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

501

2390

1.49

15.29

1.5

g/l

0.8

0.18

305

1828

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

270

2.55

15.27

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

225

2.71

15.26

1.5

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

378

1699

1.58

15.12

1.3

u/l

349.8

558.0

1.06

351

1611

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

551

2692

1.46

14.93

1.2

1.3

u/l

53.8

34.4

1.36

463

2318

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.50

14.93

1.0

1.3

ng/l

5590.0

2558.6

0.49

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

136

447

2.16

14.82

1.9

1.4

u/ml

49466.5

37303.8

0.14

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

275

3187

0.61

14.74

1.6

1.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

237

949

1.77

14.66

1.7

1.6

umol/l

64.4

71.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

139

463

2.13

14.66

1.1

miu/ml

1659.2

1545.9

0.56

139

463

(3028433) Virus identified in Specimen by Culture

144

487

2.10

14.61

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

272

2.50

14.60

1.4

11.5

10.6

0.13

147

(3027923) C peptide [Moles/volume] in Serum or Plasma

204

782

1.85

14.54

1.4

1.3

nmol/l

1.1

1.2

0.97

134

615

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

199

2.78

14.52

1.6

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

116

363

2.27

14.23

2.1

1.6

—

(3012441) Differential panel - Pleural fluid

412

1921

1.53

14.06

1.4

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

733

3811

1.37

13.99

1.3

u/ml

5.1

6.6

0.45

136

600

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

176

2.86

13.93

1.4

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

291

1254

1.65

13.85

1.2

u/ml

36.2

62.2

0.69

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

630

3200

1.40

13.83

1.2

u/ml

6.7

4.6

0.25

233

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

7.41

13.75

9.3

9.2

44.2

43.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1006

5498

1.31

13.72

1.6

1.5

—

(3011985) Renin [Units/volume] in Plasma

454

2174

1.49

13.66

1.3

1.4

mu/l

51.0

57.6

0.45

378

1931

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

294

3293

0.63

13.65

1.4

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

723

3768

1.37

13.61

1.3

u/ml

6.2

5.3

0.10

373

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

494

2412

1.46

13.48

1.2

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

131

443

2.10

13.35

5.3

mmol/l

24.4

25.0

0.67

123

406

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

271

1162

1.66

13.18

1.2

u/ml

2.4

6.5

0.98

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

119

390

2.16

13.12

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

418

1989

1.49

13.00

1.3

nmol/l

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

281

1221

1.64

12.98

1.2

u/ml

73.6

85.4

0.31

(3016038) Potassium [Moles/volume] in Urine

271

1169

1.65

12.89

1.3

1.1

mmol/l

31.6

35.2

1.99

227

989

(40768806) Pleura Pathology biopsy report

417

1987

1.49

12.88

1.5

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

281

1226

1.63

12.78

1.2

u/ml

37.4

44.7

0.32

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5250

33631

1.13

12.75

4.5

3.5

ng/l

429.7

394.0

0.24

4392

27455

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

207

2.60

12.57

1.4

1.2

ng/l

1088.3

150.2

0.45

142

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

181

701

1.83

12.57

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

136

3.02

12.55

1.6

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

289

2.33

12.49

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

586

3003

1.39

12.27

1.6

1.5

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.43

12.14

1.1

u/field

1.1

0.04

(3036782) Glucose [Moles/volume] in Pleural fluid

359

1680

1.52

12.12

1.4

1.3

mmol/l

6.8

6.2

3.24

341

1545

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

170

654

1.85

12.08

1.2

56.3

58.8

0.12

(40758558) Short blood count panel - Blood

6485

42177

1.11

11.99

6.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

261

1138

1.63

11.94

1.3

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.45

11.83

4.2

3.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

248

2.40

11.82

2.9

2.7

—

(3008898) HLA-B27 [Presence]

695

3687

1.34

11.73

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

3.50

11.70

1.2

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1368

7921

1.23

11.60

5.7

3.4

mmol/l

24.0

24.3

2.25

1202

7081

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

158

603

1.86

11.53

1.9

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

158

603

1.86

11.53

1.9

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

273

2.31

11.53

1.8

1.6

au/ml

262.7

68.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

203

836

1.72

11.52

1.7

1.6

mmol/24h

5.3

5.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

298

1358

1.56

11.38

2.0

1.8

mg/l

3.9

4.1

0.43

279

1292

(44806420)

149

561

1.88

11.34

2.1

2.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

284

2.27

11.34

1.2

mmol/l

1.3

1.7

2.45

173

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

112

383

2.07

11.17

1.2

—

(4015189)

129

465

1.97

11.16

2.7

2.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

302

1387

1.55

11.15

1.4

1.3

nmol/l

1.4

0.24

262

1255

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

158

613

1.83

10.98

2.0

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

226

2548

0.63

10.91

1.5

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

715

3853

1.32

10.88

4.4

3.4

mg/l

28.5

28.4

0.02

470

2482

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

285

2.24

10.87

2.5

2.6

au/ml

172.7

166.3

0.03

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

273

1234

1.57

10.82

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1167

6703

1.24

10.68

2.3

g/l

3.1

0.37

859

5230

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

176

712

1.75

10.67

1.1

ratio

1.1

0.33

230

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

761

4151

1.31

10.62

1.3

1.2

u/ml

48.8

41.7

0.28

236

(3006969) Lambda light chains [Mass/volume] in Urine

4.85

10.60

1.1

g/l

0.0

0.1

0.41

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

298

1382

1.53

10.56

1.7

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

298

1382

1.53

10.56

1.7

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

298

1382

1.53

10.56

1.7

1.4

—

(1002224) Polysomnography panel

530

5064

0.74

10.53

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

413

2047

1.43

10.53

1.3

pmol/l

280.7

277.7

0.05

307

1583

(40763791) Oxygen content in Venous blood by calculation

4.92

10.36

3.8

5.3

ml/dl

11.7

12.4

0.28

(3047181) Lactate [Moles/volume] in Blood

904

5061

1.27

10.33

6.0

5.2

mmol/l

1.3

0.44

789

4448

(3028679) Herpes simplex virus Ab [Presence] in Serum

142

544

1.85

10.30

1.1

—

(3045716) Anion gap in Serum or Plasma

178

734

1.72

10.13

3.2

2.4

mmol/l

9.0

9.1

0.13

137

548

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

282

1306

1.53

10.08

1.5

1.4

u/l

13.4

12.6

1.30

269

1256

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

223

980

1.62

9.98

1.4

1.3

u/ml

2.2

1.1

0.60

106

504

(3043409) Potassium [Moles/volume] in Arterial blood

935

5290

1.26

9.80

4.1

3.9

mmol/l

3.9

2.95

859

4947

(3035082) Kappa light chains [Mass/volume] in Urine

4.49

9.76

1.1

g/l

0.1

0.0

1.18

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

299

1413

1.50

9.75

1.5

1.6

u/ml

23.1

25.9

0.51

317

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

661

3584

1.31

9.68

1.6

1.7

iu/l

19.1

7.2

0.39

226

1178

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

582

0.28

9.67

2.0

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

314

2.10

9.66

2.8

3.2

mg/l

6.1

7.7

0.95

258

(3027944) Amphetamines [Presence] in Urine

187

2137

0.62

9.63

2.2

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7326

48379

1.10

9.63

4.7

4.6

21.9

22.0

0.16

4144

25136

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

142

557

1.81

9.60

1.1

u/ml

3.9

17.6

1.00

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

334

2.06

9.58

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.72

9.53

1.4

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

386

1929

1.42

9.46

2.1

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

110

400

1.95

9.37

2.3

2.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

328

2.05

9.33

1.8

1.4

ng/l

156.0

101.9

2.23

328

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

188

806

1.66

9.31

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

231

2.27

9.30

1.3

18.1

25.4

1.15

188

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

130

503

1.83

9.20

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

206

908

1.61

9.16

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

332

1624

1.45

9.15

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

204

900

1.61

9.04

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

285

1358

1.49

8.98

1.3

u/l

12.4

14.0

0.46

259

1271

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

140

2.63

8.92

1.2

2.4

mmol/l

1.6

1.3

0.22

(3014007) Fractional oxyhemoglobin in Arterial blood

1816

11071

1.17

8.88

7.3

8.2

93.6

93.8

0.33

1802

11039

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

146

593

1.75

8.83

2.8

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

382

1931

1.41

8.82

1.4

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

197

2178

0.64

8.81

2.1

1.7

—

(3003129) Base excess in Capillary blood by calculation

112

419

1.90

8.81

1.7

mmol/l

0.6

0.7

0.09

107

396

(3020191) Ethanol [Moles/volume] in Serum or Plasma

237

1091

1.54

8.78

1.4

promille

1.1

1.3

0.92

164

841

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1058

6150

1.23

8.72

2.7

2.4

g/l

1.1

1.0

0.30

825

5240

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2978

18833

1.13

8.70

2.8

2.4

umol/l

9.3

9.4

0.07

2457

16347

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

163

2.48

8.69

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

416

2141

1.38

8.65

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

202

902

1.59

8.55

2.0

2.1

e6/l

497.7

525.4

0.21

173

752

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

350

1.97

8.49

1.8

1.9

mg/l

9.3

9.0

0.12

284

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

445

2323

1.36

8.48

1.3

nmol/l

0.1

0.3

2.15

190

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

8.37

8.46

2.8

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

444

2322

1.36

8.37

1.3

nmol/l

4.8

1.4

0.59

430

2215

(3028300) Cannabinoids [Presence] in Urine

202

2195

0.65

8.36

2.1

1.7

—

(3027008) Opiates [Presence] in Urine

202

2191

0.65

8.29

2.1

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1461

8808

1.18

8.19

1.2

iu/ml

125.6

138.0

0.65

492

3207

(3028308) Erythrocytes [#/volume] in Pleural fluid

389

2002

1.38

8.12

1.4

1.5

e6/l

55076.2

56943.2

0.05

213

1201

(3008116) Ketones [Moles/volume] in Urine by Test strip

307

2.01

8.12

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

329

1647

1.42

8.07

1.3

1.4

e6/l

183041.8

122451.0

0.60

227

1125

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

191

856

1.58

8.00

2.1

2.2

e9/l

0.2

0.20

172

746

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

124

2.63

7.92

1.4

1.2

pmol/l

11.3

18.6

0.88

109

(3043238) Trisomy 21 risk [Likelihood] in Fetus

590

0.36

7.78

1.4

1.5

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

130

2.56

7.71

3.0

1.8

64.6

56.0

0.84

(3023199) Leukocytes [#/volume] in Pleural fluid

419

2204

1.35

7.66

1.5

e6/l

2080.7

3342.4

0.91

308

1582

(40768795) Lymph node Pathology biopsy report

332

1682

1.40

7.64

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

574

0.36

7.64

1.3

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5311

34886

1.09

7.60

3.4

3.2

ug/l

0.8

1.61

3857

24563

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

379

1966

1.37

7.58

1.1

g/l

1.6

1.5

1.31

340

1753

(3005033) Fetal Nuchal fold Thickness US

571

0.36

7.56

1.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

128

526

1.73

7.51

1.3

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

104

403

1.83

7.42

1.7

2.6

ug/l

1.2

0.9

0.73

388

(3048879) Bone marrow aspiration report

114

455

1.78

7.40

1.5

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

615

0.39

7.35

1.2

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

303

1525

1.41

7.27

1.5

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

419

2224

1.34

7.24

1.1

iu/ml

49.1

5687.9

0.56

429

(3009015) Lactate [Moles/volume] in Synovial fluid

183

2.25

7.21

1.3

mmol/l

5.5

6.5

0.90

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

300

1511

1.41

7.17

1.7

1.4

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

102

2.71

7.14

3.0

1.7

10.3

22.9

1.55

(3011325) HIV 1+2 Ab [Presence] in Serum

3.54

7.02

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

192

2026

0.67

6.97

2.1

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4356

28462

1.10

6.94

3.4

2.9

e6/l

2.4

2.6

0.89

2746

15035

(3024869) Neuronal Ab [Presence] in Serum

311

1.91

6.92

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

305

1552

1.40

6.89

2.4

2.3

0.3

0.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

265

2632

0.71

6.89

1.6

1.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

144

627

1.63

6.86

1.5

1.3

umol/l

23.2

25.1

0.29

128

594

(3045683) HLA typing for celiac disease panel - Blood or Tissue

151

666

1.61

6.83

1.0

—

(3012898) Urea [Moles/volume] in Urine

130

2.45

6.81

1.2

1.3

mmol/l

160.6

163.9

0.05

113

(3023383) Lactate [Moles/volume] in Pleural fluid

130

554

1.66

6.73

1.3

mmol/l

3.6

0.03

121

509

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

118

2.52

6.73

6.8

4.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

107

432

1.76

6.72

1.1

—

(3025130) Human papilloma virus identified in Specimen

136

1528

0.63

6.67

1.5

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1785

11115

1.15

6.62

7.2

8.0

1.3

1.4

0.51

1770

11037

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

246

1215

1.44

6.59

1.3

titre

410.8

450.9

0.07

103

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2654

20787

0.89

6.59

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

315

1625

1.38

6.58

1.7

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

189

886

1.51

6.58

1.1

mg/l

313.7

300.2

0.25

153

781

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

107

437

1.74

6.48

1.5

ug/l

0.5

0.4

1.15

279

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

112

2.53

6.46

1.2

1.1

13.9

28.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.40

6.38

1.0

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1773

11065

1.14

6.37

7.4

8.1

0.7

0.59

1756

10998

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

462

0.35

6.34

1.3

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

239

1184

1.43

6.32

1.3

titre

63.5

64.7

0.03

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

158

2.24

6.25

1.3

1.2

ug/l

78.2

119.7

1.41

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

214

2.05

6.24

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.33

6.21

1.3

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

451

2485

1.29

6.05

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

116

498

1.65

5.90

2.0

1.5

umol/l

2.0

0.15

110

464

(44816559) Phosphatidylethanol [Mass/volume] in Blood

411

2245

1.30

5.90

1.2

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

159

1679

0.67

5.87

2.3

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

205

2.04

5.86

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

220

2.00

5.83

16.9

7.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

372

1.75

5.82

1.3

1.1

107.1

106.7

0.03

336

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

255

1.92

5.79

15.8

6.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

196

953

1.46

5.77

1.7

2.0

u/field

2.6

0.00

156

661

(3024263) Appearance of Synovial fluid

191

924

1.47

5.77

1.8

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

424

3826

0.78

5.74

1.6

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1515

9428

1.15

5.71

7.3

8.3

mmol/l

24.3

24.4

0.50

1376

8747

(3051101) Glucose [Moles/volume] in Cord blood

334

1.78

5.63

6.0

6.1

—

(3045142) Bone marrow Pathology biopsy report

367

1988

1.31

5.62

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

728

4272

1.21

5.62

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1524

9514

1.14

5.50

1.3

au/ml

55.3

52.4

0.15

408

(4027681)

144

665

1.54

5.45

1.5

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

174

837

1.47

5.44

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

371

1.72

5.36

1.2

1.1

85.3

88.1

0.37

162

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

190

933

1.44

5.35

1.2

1.1

mg/l

44.5

44.8

0.03

137

795

(40762814) Titanium [Mass/volume] in Blood

340

1.75

5.33

2.3

ug/l

3.8

3.5

0.10

106

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

289

1.81

5.29

1.2

1.1

pmol/l

2.3

3.7

—

(3044290) Cell count panel - Cerebral spinal fluid

540

3094

1.24

5.28

1.4

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1402

8731

1.14

5.26

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

782

4656

1.19

5.20

1.7

—

(3047189) Immunofixation for 24 hour Urine

173

840

1.46

5.18

1.8

1.6

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.86

5.11

1.1

u/field

0.7

1.5

0.84

(3045788) Cell count panel - Pleural fluid

319

1720

1.32

5.10

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

330

1.74

5.05

4.2

5.4

67.2

72.5

0.77

262

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

746

0.55

4.96

1.4

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

164

796

1.46

4.94

1.6

umol/l

14.4

9.2

1.22

119

577

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

649

3824

1.21

4.87

1.3

mg/l

548.7

560.8

0.20

612

3626

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.13

4.83

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

116

2.26

4.79

2.4

2.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

368

1.68

4.77

1.2

1.1

91.4

88.4

0.33

167

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1657

10504

1.12

4.73

2.5

2.4

au/ml

31.7

29.4

0.16

453

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

285

0.30

4.72

1.0

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

527

4535

0.82

4.71

1.6

1.5

mg/l

3.9

3.2

0.73

408

3219

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

127

2.18

4.64

1.2

1.1

—

(3039000) Anion gap in Blood

614

3622

1.20

4.57

7.0

5.8

mmol/l

11.1

11.2

0.34

558

3246

(3018572) Chloride [Moles/volume] in Blood

614

3623

1.20

4.56

7.0

5.8

mmol/l

104.6

104.9

0.87

558

3247

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

138

659

1.48

4.55

2.0

1.5

105.9

97.8

1.66

130

610

(3035947) Staphylolysin Ab [Units/volume] in Serum

158

776

1.44

4.52

1.2

1.1

iu/ml

4.7

4.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

137

1407

0.69

4.49

1.6

1.5

—

(40768441) Liver Pathology biopsy report

211

1092

1.37

4.48

1.3

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

837

6884

0.86

4.48

1.6

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

139

669

1.47

4.42

1.1

u/l

1.1

0.02

326

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.19

4.41

1.3

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

345

1920

1.28

4.41

1.3

1.2

u/ml

58.3

60.2

0.05

122

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

572

3365

1.21

4.40

1.3

mmol/l

4.1

3.8

5.32

541

3154

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

189

965

1.39

4.37

1.8

2.1

nmol/l

15.4

16.4

0.90

178

902

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4636

30937

1.07

4.32

3.2

2.7

e6/l

1.3

0.03

3008

17386

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

134

644

1.48

4.30

1.4

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

441

1.58

4.26

1.9

1.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

242

1.79

4.23

1.5

ug/l

111.1

111.4

0.01

198

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.89

4.21

1.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

197

1020

1.37

4.20

2.1

2.3

e6/l

654.2

776.7

0.44

106

375

(3011288) Drugs identified in Urine by Screen method

143

1436

0.70

4.16

2.9

2.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

390

2220

1.25

4.15

2.1

2.3

u/ml

2295.5

835.0

0.40

376

2184

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3493

23115

1.08

4.08

9.0

7.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

113

531

1.51

4.07

3.8

1.6

165.2

153.7

0.58

106

491

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

181

1740

0.73

4.04

1.2

mmol/l

7.9

7.6

0.53

126

1223

(3025315) Body weight

112

2.15

3.98

5.5

4.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

393

1.59

3.97

1.3

nmol/l

95.5

144.4

3.34

275

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

227

1.78

3.93

1.1

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

921

5697

1.15

3.91

2.3

2.2

g/l

37.0

37.5

1.58

730

4872

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

384

1.59

3.90

1.1

—

(4024509)

305

1701

1.27

3.89

1.7

1.6

—

(3024928) Oxygen saturation in Venous blood

565

3367

1.19

3.84

3.6

2.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

230

1.76

3.77

1.1

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.28

3.77

1.1

1.3

u/field

0.9

1.1

0.73

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

178

928

1.36

3.70

1.8

1.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

217

1.76

3.64

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1698

10946

1.10

3.63

2.1

nmol/l

11.7

12.2

1.47

1403

9490

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

893

5544

1.14

3.63

1.5

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

162

1.88

3.55

5.7

6.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

224

1.74

3.55

1.3

48.8

49.2

0.01

103

(3009871) Measles virus Ab [Titer] in Serum

350

1.58

3.50

1.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

109

2.08

3.49

3.9

2.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

407

1.53

3.47

1.1

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.40

3.46

1.3

1.2

g/l

0.1

0.46

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

352

1.57

3.43

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

414

1.52

3.43

1.4

g/l

14.1

13.1

0.54

318

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.27

3.36

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

163

853

1.35

3.35

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

163

854

1.35

3.32

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

272

1.64

3.32

1.7

1.5

—

(44813793)

187

1001

1.32

3.31

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

141

1.91

3.31

1.2

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

458

1.49

3.30

1.5

1.3

umol/l

2.9

3.2

0.45

419

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

108

528

1.45

3.28

1.3

ug/l

529.0

247.7

0.47

288

(3023511) Choriogonadotropin [Units/volume] in Urine

705

0.63

3.27

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

374

1.53

3.25

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

110

543

1.44

3.19

1.2

g/l

0.4

0.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

499

2996

1.18

3.19

1.3

1.2

u/ml

46.4

47.8

0.07

286

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.00

3.18

1.1

1.5

u/field

0.3

0.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

355

1.54

3.12

1.1

umol/24h

0.7

0.67

165

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

554

3362

1.17

3.12

1.6

1.4

e6/l

891.0

2022.4

0.94

479

2733

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

766

6162

0.88

3.12

1.6

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

170

907

1.33

3.10

1.0

1.1

nmol/l

6.1

7.1

0.14

189

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

209

1148

1.29

3.10

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

426

1.48

3.04

1.3

35.2

36.6

0.12

278

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

584

3567

1.16

3.04

1.1

u/ml

9.1

8.6

0.05

325

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

552

3358

1.17

3.03

1.5

1.4

e6/l

36.9

30.9

0.11

439

2601

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

691

0.64

3.02

1.2

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

404

1.49

3.01

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

2.23

3.00

1.1

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

690

0.65

3.00

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

690

0.65

3.00

1.2

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.32

3.00

1.2

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

169

907

1.32

2.98

1.4

1.5

u/l

6.5

6.1

0.13

139

755

(44806118)

287

1646

1.24

2.98

1.4

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

688

0.65

2.97

1.2

1.4

—

(44790048)

287

1647

1.24

2.97

1.4

1.3

—

(44790047)

287

1647

1.24

2.97

1.4

1.3

—

(44790049)

287

1647

1.24

2.97

1.4

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

284

1629

1.24

2.95

1.4

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

6.20

2.94

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

118

600

1.39

2.94

1.6

1.7

umol/l

69.4

125.3

3.22

308

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

162

867

1.32

2.92

3.3

3.2

—

(3027874) Urate [Moles/volume] in Urine

2.40

2.91

1.1

mmol/l

1.5

1.7

0.17

(3020491) Glucose [Moles/volume] in Blood

201

1110

1.28

2.89

1.6

2.0

mmol/l

7.7

7.2

1.09

125

801

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

259

0.44

2.88

1.8

2.4

—

(3023410) Appearance of Cerebral spinal fluid

169

1553

0.77

2.87

1.7

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

159

1.78

2.87

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

159

1.78

2.87

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

234

1.63

2.86

1.3

1.2

mmol/l

1.4

1.6

0.10

153

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

409

1.47

2.85

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

332

2828

0.83

2.84

3.3

3.6

u/ml

43.1

42.6

0.02

319

2745

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

125

646

1.37

2.84

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

139

1.83

2.83

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1429

9262

1.10

2.81

9.1

8.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

451

2719

1.18

2.80

3.4

2.4

64.6

61.8

1.78

444

2705

(3050129) First trimester maternal screen panel - Serum or Plasma

837

0.69

2.77

1.5

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

304

1.54

2.73

1.3

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

640

0.65

2.72

13.0

15.8

nmol/l

1311.1

1431.8

0.69

606

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

121

628

1.37

2.70

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

416

2501

1.18

2.69

1.9

ug/l

22.2

25.4

0.63

406

2449

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

211

1.65

2.68

1.5

1.3

79.8

72.4

1.19

175

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

121

629

1.36

2.67

1.6

nmol/l

4.0

5.1

0.26

101

533

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

102

516

1.40

2.65

1.4

pmol/l

16.9

15.3

1.64

426

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2067

15678

0.93

2.64

2.8

2.4

u/l

82.3

41.1

0.59

1724

13314

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

1.90

2.63

1.0

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

619

3844

1.14

2.62

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

177

976

1.29

2.61

2.2

2.0

umol/l

13.3

26.6

1.35

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

619

3845

1.14

2.61

1.3

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

4.36

2.60

7.5

9.6

e6/l

11550.4

45.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

159

1.74

2.60

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

159

865

1.30

2.60

1.2

u/l

208.8

354.0

1.97

147

801

(21494434) Karyotype in Bone marrow

268

1552

1.22

2.60

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

102

519

1.39

2.58

1.0

1.1

101.6

95.6

0.99

396

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.98

2.57

1.2

1.1

u/l

43.2

120.5

0.55

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

4.96

2.56

1.0

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.11

2.54

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

508

0.63

2.52

2.4

1.8

ug/l

23.7

5.6

0.41

339

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

683

4283

1.13

2.51

2.1

1.9

92.0

90.7

0.79

624

3971

(3022229) Phosphate [Moles/volume] in Urine

2.28

2.49

1.5

1.7

mmol/l

13.7

17.4

1.19

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

178

1.67

2.46

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.15

2.43

1.3

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

168

1.69

2.42

1.5

1.7

umol/l

42.7

45.6

0.33

168

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

179

1.66

2.42

1.0

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

855

5448

1.11

2.41

2.5

2.3

g/l

0.1

0.0

0.78

767

4940

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.74

2.37

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

133

1.76

2.32

1.4

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

166

1.66

2.27

1.2

1.1

u/l

18.0

21.3

0.40

105

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

117

623

1.33

2.27

1.1

ng/l

900.1

828.0

0.05

147

(3033799) Differential panel - Peritoneal fluid

103

538

1.36

2.27

2.6

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.36

2.26

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.13

2.24

5.7

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

5510

40427

0.96

2.24

4.5

3.7

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.16

2.24

1.1

mmol/l

5.8

5.3

0.29

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

603

0.68

2.23

9.2

11.3

nmol/l

823.9

833.0

0.05

573

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

561

3511

1.13

2.18

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

115

1.79

2.16

1.4

1.2

—

(3018133) Calcium [Moles/volume] in Urine

213

1.56

2.16

1.8

mmol/l

2.3

2.8

0.84

191

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2373

15866

1.06

2.15

1.5

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

184

1609

0.81

2.15

1.1

u/ml

1.1

0.00

652

(3003888) Timothy IgE Ab [Units/volume] in Serum

191

1663

0.81

2.14

1.1

u/ml

4.4

3.8

0.21

776

(3019174) dRVVT (LA screen)

105

1.82

2.14

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

311

1.46

2.14

1.2

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

100

1.84

2.13

1.2

1.5

ml/s/173m2

0.5

1.1

3.68

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.92

2.12

1.1

u/l

2.3

3.3

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

2.11

0.0

1.0

—

3.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

479

1.36

2.09

2.2

2.0

u/l

63.1

42.4

0.31

442

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1078

7005

1.09

2.09

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

425

1.38

2.09

1.3

1.4

20.6

21.7

0.12

359

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

154

864

1.26

2.06

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

160

902

1.26

2.06

2.3

2.1

ug/min

132.4

98.7

0.26

196

(3009214) Lutropin [Units/volume] in Serum or Plasma

437

2702

1.15

2.05

1.4

u/l

13.4

11.5

1.45

354

2155

(3028707) Methadone [Presence] in Urine by Screen method

114

1048

0.77

2.05

2.4

2.1

—

(3044009) aPTT.lupus sensitive (LA screen)

112

1.77

2.05

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

409

1.39

2.04

1.1

—

(3051651) Icteric interference index of Serum or Plasma

166

942

1.25

2.02

4.7

3.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

178

1.59

2.00

1.1

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

156

1.63

2.00

3.4

1.4

mmol/l

9.1

7.0

3.47

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

334

1.42

1.98

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.36

1.97

2.7

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

267

2231

0.85

1.96

1.3

—

(3001729) Color of Synovial fluid

157

1.62

1.95

1.4

1.7

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

294

1.45

1.95

1.8

1.3

titre

64.8

196.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

127

702

1.28

1.94

1.5

1.6

ug/l

12.7

8.9

0.57

110

642

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

115

0.37

1.92

1.0

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

102

941

0.77

1.91

1.3

pmol/l

323.6

67.7

0.70

287

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

162

0.44

1.90

1.1

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

415

1.37

1.90

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

116

636

1.29

1.89

3.0

2.9

mu/l

23.6

25.5

0.22

103

595

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

105

963

0.77

1.89

1.1

1.0

u/ml

1.3

0.3

0.51

227

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

187

1.55

1.87

1.1

1.2

nmol/l

7.7

312427.5

1.34

153

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.36

1.83

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

4.43

1.80

17.6

9.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

140

0.45

1.76

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.30

1.74

1.2

mmol/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

191

1.52

1.73

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

392

1.36

1.73

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

351

1.37

1.69

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

163

945

1.22

1.69

1.3

1.4

umol/l

13.0

13.2

0.18

156

882

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

233

1.46

1.68

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

463

1.32

1.64

1.2

g/l

0.3

1.12

369

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

631

0.74

1.64

13.1

12.4

mmol/l

0.7

0.6

0.69

579

(3001964) Herpes simplex virus Ag [Presence] in Specimen

390

1.34

1.63

1.6

1.1

—

(3024316) Viscosity of Plasma

1.79

1.57

1.7

2.1

mpas

1.6

1.8

0.67

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

267

1631

1.16

1.57

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

421

3342

0.89

1.56

1.4

1.3

iu/l

33.4

36.1

0.88

354

2836

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

303

1869

1.15

1.56

3.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

873

0.79

1.56

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.82

1.56

1.3

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.09

1.55

1.6

1.3

nmol/l

449.0

501.9

0.12

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.02

1.54

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

134

0.48

1.53

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

197

1.47

1.53

1.1

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

113

995

0.80

1.51

1.8

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

146

851

1.22

1.48

1.1

—

(3000492) Spirometry study

2038

13737

1.05

1.48

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.05

1.47

1.4

1.1

—

(40757373) Influenza virus identified in Isolate

288

1.38

1.47

1.6

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

110

0.45

1.46

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

176

1.49

1.46

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

219

1.42

1.40

2.5

2.4

pmol/l

77.3

73.3

0.08

192

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

152

1286

0.84

1.39

1.3

1.4

u/l

31.9

34.7

0.37

115

1043

(3002331) Protein [Mass/volume] in Peritoneal fluid

383

1.31

1.38

1.8

1.3

g/l

27.3

45.2

0.59

297

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

349

2195

1.13

1.38

1.5

1.6

—

(3036489) Thrombin time

850

5588

1.08

1.36

1.9

1.8

22.0

21.7

0.59

726

4936

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

752

0.79

1.34

4.4

4.9

u/ml

48.1

1461.1

0.75

117

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.66

1.33

1.7

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

868

0.81

1.32

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.77

1.31

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

556

1.25

1.31

2.2

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

556

1.25

1.31

2.2

2.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

317

1990

1.13

1.31

1.2

u/ml

3.9

4.2

0.09

117

662

(3001218) Citrate [Mass/time] in 24 hour Urine

2.95

1.30

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

101

1.61

1.29

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

247

1.38

1.28

1.2

1.1

99.9

81.8

0.90

(3010370) Gastrin [Moles/volume] in Serum or Plasma

235

1.39

1.28

1.5

1.8

pmol/l

31.2

67.5

2.55

192

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

110

634

1.23

1.28

1.1

u/ml

8.0

5.5

0.20

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

432

1.28

1.2

115.8

112.4

0.52

375

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

194

1.42

1.26

1.3

1.2

u/l

67.5

252.4

0.59

137

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

248

1.37

1.26

1.1

78.0

73.8

0.17

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

309

1.33

1.26

3.7

5.5

u/l

38.5

52.7

0.77

122

(3035611) Eosinophils/100 leukocytes in Synovial fluid

136

1.51

1.25

1.5

1.8

0.9

0.02

107

(3022689) Creatine [Moles/volume] in Urine

440

1.27

1.24

1.4

1.5

—

(40763590) HLA-DQ beta [Type]

2.27

1.24

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.27

1.24

1.3

1.0

titre

3142.5

1759.2

—

(40760410) HLA-B [Type] by High resolution

2.27

1.24

1.0

—

(40760409) HLA-A [Type] by High resolution

2.27

1.24

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.27

1.24

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

177

1.44

1.24

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

183

1.43

1.24

2.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

213

1.40

1.23

3.8

3.0

umol/l

42.2

39.7

0.27

181

(3013139) Helicobacter pylori Ag [Presence] in Stool

1614

10877

1.05

1.23

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

774

5100

1.08

1.21

2.5

2.3

g/l

0.0

0.41

693

4611

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

937

6217

1.07

1.20

1.1

u/ml

6.6

4.2

0.16

103

(40768793) Breast Pathology biopsy report

552

3590

1.09

1.19

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

291

1831

1.13

1.19

1.1

122.7

119.7

0.85

253

1621

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

567

3693

1.09

1.18

1.3

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

476

1.25

1.17

1.8

2.0

10.0

10.9

0.22

430

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

109

0.52

1.16

1.0

1.2

—

(3013862) HLA-DP [Type]

2.10

1.15

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.44

1.15

2.2

7.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.36

1.13

1.0

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.02

1.12

1.1

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

429

1.25

1.10

1.9

1.5

ug/l

9.8

9.2

0.53

429

(4034850)

742

5624

0.93

1.10

10.1

10.9

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

387

1.26

1.07

4.5

1.7

179.5

178.9

0.02

360

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

420

1.25

1.04

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

268

1695

1.12

1.04

1.2

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

173

1405

0.87

1.02

1.1

u/ml

1.3

1.7

0.37

314

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

173

1.39

1.02

1.7

1.9

umol/l

14.7

18.3

1.27

173

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.56

1.01

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.81

1.01

1.1

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

559

3674

1.08

0.99

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

170

1049

1.15

0.98

1.3

1.2

u/l

107.6

85.9

1.40

155

904

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

690

0.82

0.98

1.2

1.3

mmol/l

6.1

0.01

648

(3041184) Isoniazid [Presence] in Urine

2.36

0.96

2.2

3.2

—

(3000060) B lymphocytes [#/volume] in Blood

325

1.26

0.93

1.6

2.0

e6/l

193.0

1707.1

1.10

175

(3036603) Volume of Urine

187

1167

1.14

0.93

1.7

1.6

1726.3

2004.7

2.08

278

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

395

1.24

0.93

1.7

—

(3049242) von Willebrand panel - Platelet poor plasma

1.86

0.93

1.3

2.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

201

1261

1.13

0.92

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

661

0.82

0.92

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

345

2231

1.10

0.91

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

544

1.20

0.91

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

139

0.61

0.90

1.0

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

754

5029

1.06

0.90

2.6

2.3

g/l

0.0

0.00

690

4597

(3032743) Legionella sp IgG Ab [Presence] in Serum

106

1.47

0.89

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

565

4282

0.93

0.89

1.3

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

481

1.21

0.89

1.7

2.0

29.3

29.2

0.03

451

(3051611) Lipemic interference index of Serum or Plasma

292

1877

1.10

0.88

4.1

3.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.87

1.2

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

304

1.26

0.85

3.3

2.8

u/l

435.5

1639.6

1.35

274

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.77

0.83

2.5

2.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.77

0.83

1.4

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

108

1.44

0.83

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

767

0.85

0.82

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

248

1589

1.11

0.82

1.7

2.0

u/l

3805.3

4368.4

0.12

593

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

187

1.33

0.82

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

218

1.30

0.82

1.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.60

0.81

1.1

1.0

u/ml

0.1

0.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

269

1.26

0.80

1.1

—

(3034426) Prothrombin time (PT)

403

1.21

0.80

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

757

0.85

0.80

1.2

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.51

0.80

1.2

1.0

—

(3002619) Bacteria identified in Specimen by Culture

352

1.23

0.79

1.1

1.3

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.79

0.0

1.1

—

(3006462) Nitrate [Presence] in Urine

131

810

1.15

0.79

4.0

3.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

181

1143

1.12

0.79

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

598

3982

1.06

0.78

2.8

2.1

201.6

197.9

0.44

561

3731

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.69

0.78

67.5

8.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

140

1126

0.88

0.78

1.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

379

1.21

0.77

2.0

2.4

—

(3034614) HLA Ag [Interpretation]

2.21

0.77

1.2

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.21

0.77

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

248

0.74

0.76

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

166

0.68

0.76

1.2

1.1

u/ml

82.9

59.9

0.45

158

(3000285) Sodium [Moles/volume] in Blood

240

1.27

0.75

1.3

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

132

0.64

0.75

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

298

1938

1.09

0.74

1.1

au/ml

30.5

12.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.59

0.74

1.1

nmol/l

243.4

296.7

0.58

(3050794) Legionella sp Ab [Presence] in Serum

135

1.36

0.74

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

240

1865

0.91

0.74

1.2

1.1

u/ml

1.8

1.2

0.40

724

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.54

0.74

1.0

u/ml

0.3

0.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.66

0.73

1.0

u/ml

0.0

0.8

—

(3013762) Body weight Measured

1.63

0.73

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

559

0.84

0.73

1.5

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

197

0.72

1.6

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

298

1942

1.09

0.72

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

142

1.35

0.72

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

167

1.31

0.71

1.2

1.1

umol/24h

1.8

1.7

0.35

167

(3004716) Salmonella sp identified in Stool by Organism specific culture

868

6438

0.95

0.71

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

288

1.23

0.69

1.1

u/ml

0.7

4.6

0.65

146

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.50

0.65

1.1

1.0

u/ml

0.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

193

0.73

0.65

12.2

11.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.62

0.65

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

167

1066

1.11

0.64

1.1

mg/l

297.5

290.4

0.62

148

932

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

366

2421

1.07

0.63

1.9

pmol/l

191.5

193.5

0.12

348

2236

(3015076) Soybean IgE Ab [Units/volume] in Serum

450

0.83

0.63

1.0

u/ml

0.1

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

119

746

1.13

0.63

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

676

4557

1.05

0.62

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

109

0.65

0.62

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

171

1.28

0.62

1.5

1.8

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.62

0.0

1.0

—

21.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

136

861

1.12

0.61

1.6

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

151

1185

0.90

0.60

1.1

1.0

u/ml

3.3

3.4

0.03

447

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

170

1324

0.91

0.59

4.3

5.0

u/ml

218.2

107.3

0.68

368

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.62

0.59

1.3

1.2

—

2.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

323

0.81

0.59

1.6

1.9

ug/l

2.6

2.5

0.02

188

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

160

1027

1.10

0.58

1.3

1.2

u/l

22.3

24.3

0.31

141

868

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

119

752

1.12

0.57

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

318

2104

1.07

0.57

3.4

3.3

nmol/l

5.7

9.4

0.73

311

2044

(44806071)

174

1.26

0.56

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

130

1.31

0.56

1.2

1.1

u/l

8.9

12.3

0.59

130

(3014891) Appearance of Pleural fluid

251

1.21

0.55

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

147

944

1.10

0.54

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

136

870

1.11

0.54

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

1.50

0.52

2.5

1.7

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

267

1763

1.07

0.52

3.0

3.8

u/ml

41.8

56.5

0.72

260

1736

(3021387) Prolactin [Units/volume] in Serum or Plasma

410

2746

1.06

0.52

1.9

1.7

mu/l

305.7

318.0

0.23

372

2514

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

136

873

1.10

0.51

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

5179

36168

1.02

0.50

5.2

4.3

kg/l

1.0

2.34

968

5239

(4198724)

323

0.83

0.49

1.4

2.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

133

1.28

0.49

1.1

u/ml

2.9

0.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

567

1.12

0.48

1.3

1.4

59.3

56.9

0.25

477

(4211845)

137

884

1.10

0.48

4.0

3.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

115

1.29

0.47

1.0

1.2

nmol/l

16.5

15.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

405

0.86

0.47

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

420

0.86

0.47

1.3

1.1

pmol/l

345.8

265.1

0.52

298

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.46

0.47

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

189

0.79

0.46

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

188

1435

0.93

0.46

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.42

0.45

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

251

1895

0.94

0.45

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.48

0.45

1.3

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

433

0.87

0.44

2.6

2.5

nmol/l

125.1

153.5

1.44

378

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

245

1.19

0.44

2.5

3.0

u/field

0.5

0.6

0.20

245

(3023487) Leukocytes [#/volume] in Peritoneal fluid

618

1.11

0.44

2.4

1.7

e6/l

9734.1

3110.5

0.41

402

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.69

0.44

1.0

2.9

mu/l

2.1

2.0

—

(3001556) Androgen free Index in Serum or Plasma

1.45

0.43

1.4

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

143

1100

0.92

0.43

1.1

1.0

u/ml

7.9

3.3

1.18

417

(3042951) Complement C1q Ab [Units/volume] in Serum

0.63

0.43

1.2

1.1

—

18.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

131

850

1.09

0.42

1.1

iu/ml

10.4

9.9

0.05

181

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

240

1595

1.07

0.42

1.1

u/ml

4.3

3.9

0.11

605

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

286

1.16

0.42

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

393

0.86

0.42

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

339

1.15

0.42

1.2

mg/l

1.0

48.1

1.25

256

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.42

0.0

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

111

1.28

0.42

3.6

2.4

pmol/l

190.6

27.3

—

(3022725) Serotonin [Moles/volume] in Serum

1.44

0.41

1.1

1.5

nmol/l

408.8

1027.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

114

884

0.91

0.41

1.5

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

676

4617

1.04

0.41

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

331

0.86

0.41

1.2

—

710.5

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.33

0.41

1.0

8.4

8.9

0.22

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.33

0.41

1.0

1.1

35.9

36.4

0.20

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.33

0.41

1.0

20.3

22.0

0.63

(3014765) Yersinia sp identified in Stool by Organism specific culture

674

4605

1.04

0.40

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

190

1258

1.07

0.39

1.1

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

106

1.27

0.39

1.1

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

1.42

0.39

1.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.42

0.39

2.8

1.2

mmol/24h

1.9

2.3

—

(3015183) Erythrocyte sedimentation rate

531

0.89

0.38

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.74

0.36

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

140

1.21

0.35

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

191

1436

0.94

0.34

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

102

1.25

0.33

1.8

2.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

362

0.88

0.33

1.3

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

249

0.85

0.33

1.2

1.4

mu/l

498.1

1289.9

1.00

239

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

105

806

0.92

0.33

1.4

1.3

g/l

1.5

0.03

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

126

0.79

0.33

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

369

0.88

0.33

1.2

1.3

mu/l

84.5

53.7

0.54

264

(40768800) Prostate Pathology biopsy report

619

4246

1.03

0.33

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

166

1249

0.94

0.31

1.3

1.2

titre

187.0

187.9

0.01

234

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

292

0.87

0.31

3.1

ng/l

117.5

106.0

0.15

102

(40758358) Immune stain study

0.69

0.31

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

166

1246

0.94

0.30

1.2

titre

101.4

159.5

0.59

(4281824)

283

1917

1.05

0.30

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

303

1.12

0.29

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

775

5350

1.03

0.29

3.8

3.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.25

0.28

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

637

0.92

0.28

2.4

2.3

umol/l

62.0

55.5

0.77

498

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

161

0.84

0.28

1.1

1.0

ug/l

127.7

80.5

—

118

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

485

3540

0.97

0.27

1.4

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

6146

43832

0.99

0.26

4.2

3.7

86.4

88.8

10.08

5965

42749

(3044007) Cell count panel - Peritoneal fluid

497

1.08

0.25

1.7

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

927

6695

0.98

0.24

2.8

3.3

u/ml

3454.1

1524.9

0.30

777

5704

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

285

1944

1.04

0.24

1.2

u/ml

3.7

3.9

0.16

128

838

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.36

0.24

1.0

—

(3018291) Platelet Ab [Presence] in Serum

1.36

0.24

1.2

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

155

1154

0.95

0.23

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

221

1631

0.96

0.23

1.7

1.5

iu/ml

26.9

29.9

0.22

(3006567) Chloride [Moles/time] in 24 hour Urine

1.31

0.23

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

155

1153

0.95

0.23

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

114

1.18

0.23

1.2

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.75

0.23

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

155

1152

0.95

0.22

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

357

2450

1.03

0.22

1.2

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.23

0.22

1.2

1.0

u/ml

0.5

0.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

155

1151

0.95

0.22

1.2

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.22

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

155

1150

0.95

0.21

1.2

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

88.6

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

250

1.10

0.20

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

155

1148

0.96

0.20

1.2

1.1

—

(4306422)

278

1905

1.03

0.20

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

116

1.16

0.19

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

131

972

0.95

0.19

5.4

6.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2071

14819

0.99

0.19

1.7

1.6

1.5

6.67

1641

12600

(3032868) Hemoglobin electrophoresis panel in Blood

103

1.17

0.19

1.5

1.6

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

117

0.85

0.19

1.9

1.6

umol/l

0.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

147

0.87

0.19

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

478

3307

1.02

0.19

1.4

pmol/l

168.1

179.0

0.21

460

3228

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

250

0.91

0.18

1.2

1.4

76.5

72.7

1.59

240

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.18

0.17

1.4

1.3

umol/24h

343.9

333.9

0.03

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.74

0.17

2.2

1.3

1.0

0.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

267

1.09

0.17

1.2

1.7

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.16

0.16

1.1

1.3

1.4

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.22

0.16

1.0

u/ml

0.0

0.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

530

1.06

0.15

1.0

1.1

u/ml

2.3

1.0

0.28

137

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

332

2297

1.02

0.15

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.14

0.14

1.9

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.86

0.14

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

106

1.14

0.14

1.8

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

275

1900

1.02

0.14

1.0

—

(4212803)

187

0.91

0.13

1.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.18

0.13

1.3

1.6

mg/l

0.4

0.7

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.18

0.13

1.3

1.6

mg/l

2.8

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.18

0.13

1.3

1.6

mg/l

0.4

2.0

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.18

0.13

1.3

1.6

mg/l

6.2

2.0

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.18

0.13

1.3

1.6

mg/l

0.6

2.5

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.18

0.13

1.3

1.6

mg/l

0.6

1.2

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.18

0.13

1.3

1.6

mg/l

8.7

3.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

120

1.12

0.13

2.8

2.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

318

2203

1.02

0.13

4.5

4.6

umol/l

356.1

353.1

0.12

256

1880

(4268621)

188

1293

1.03

0.13

2.3

2.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

100

1.13

0.13

1.8

2.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

548

1.05

0.13

2.0

1.7

e6/l

9349.8

7550.3

0.23

277

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.85

0.12

7.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2786

19846

0.99

0.12

1.4

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

438

1.05

0.12

1.6

iu/ml

—

270.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

307

1.06

0.11

1.7

1.2

umol/l

17.9

16.6

1.24

272

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

148

1018

1.03

0.11

1.5

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

154

1120

0.97

0.10

1.4

nmol/l

0.2

0.3

0.34

779

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

349

2511

0.98

0.10

1.2

1.3

miu/ml

172.6

208.1

0.87

1033

(36303858) Crystals [Presence] in Urine

1.14

0.10

1.0

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

191

0.93

0.10

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.15

0.09

1.3

1.6

mg/l

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

109

1.10

0.09

4.2

—

(3017509) Phencyclidine [Presence] in Urine

1.13

0.09

1.5

1.3

—

(40765096) Chromosome analysis panel by Banding

529

0.96

0.09

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.12

0.09

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.09

0.09

1.0

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.09

0.09

1.7

1.2

—

(3022475) Manganese [Moles/volume] in Blood

1.11

0.09

1.1

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.10

0.08

1.0

—

(4133840)

353

1.04

0.08

1.1

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

360

1.04

0.08

1.3

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

441

0.96

0.08

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1128

8041

0.99

0.08

3.2

3.9

u/ml

48.2

68.3

1.96

1073

7756

(3037556) Urate [Mass/volume] in Serum or Plasma

528

1.03

0.08

1.4

—

(40758292) HTLV I+II Ab panel - Serum

159

1.07

0.07

1.4

1.2

—

(4094501)

646

4614

0.99

0.07

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.08

0.07

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

101

0.91

0.06

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

160

1153

0.98

0.06

1.2

mmol/l

11.9

12.0

0.06

357

(4010399)

1776

12627

1.00

0.06

1.5

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

230

1.05

0.06

1.7

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

147

1.06

0.05

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

179

0.95

0.05

1.3

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

548

1.02

0.04

1.0

1.1

u/ml

1.6

1.5

0.02

173

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

124

866

1.01

0.03

2.4

2.8

39.5

38.7

0.11

279

(36660697) Celiac disease serology panel - Serum

1660

11780

1.00

0.03

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

610

0.99

0.02

2.6

3.0

umol/l

27.6

28.8

0.47

459

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

169

0.96

0.02

1.1

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

200

1409

1.00

0.01

1.1

96.8

96.4

0.07

182

1296

(3047007) Chlamydophila sp Ab [Presence] in Serum

256

1819

1.00

0.01

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

186

1322

1.00

0.00

1.0

ng/l

40.9

44.6

0.51

129

883

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

186

1312

1.00

0.00

1.0

ng/l

328.2

334.5

0.09

131

891

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

0.95

0.00

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.95

0.00

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

131

0.97

0.00

1.4

51.8

37.8

0.69

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

100

0.99

0.00

1.3

0.1

1.9

—

(3035933) Granulocytes/100 leukocytes in Blood

268

1.00

0.00

1.6

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

259

1.01

0.00

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

180

1278

1.00

0.00

2.6

2.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

475

3364

1.00

0.00

1.6

1.7

nmol/l

45.3

44.7

0.18

454

3244

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

117

1.03

0.00

1.1

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

186

1320

1.00

0.00

1.0

ng/l

715.5

711.9

0.04

132

859

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

161

1.01

0.00

1.1

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.02

0.00

1.8

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

225

1595

1.00

0.00

3.3

2.9

mg/l

62.7

40.5

0.66

167

1127

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.01

0.00

1.4

1.1

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.1

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.92

0.00

1.0

1.1

mmol/l

8.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.84

0.00

1.2

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.84

0.00

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

65.4

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.8

—

(3035109) Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_PRESENCE_OTH_FUNCTIONAL_IMPLANTNTS – Presence of other functional implants

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Presence of other functional implants

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Presence of other functional implants (Z21_PRESENCE_OTH_FUNCTIONAL_IMPLANTNTS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints